WO2001034018A2 - Use of focused ultrasound for vascular sealing - Google Patents

Use of focused ultrasound for vascular sealing Download PDF

Info

Publication number
WO2001034018A2
WO2001034018A2 PCT/US2000/041606 US0041606W WO0134018A2 WO 2001034018 A2 WO2001034018 A2 WO 2001034018A2 US 0041606 W US0041606 W US 0041606W WO 0134018 A2 WO0134018 A2 WO 0134018A2
Authority
WO
WIPO (PCT)
Prior art keywords
puncture
site
ultrasonic
ultrasonic transducer
applicator
Prior art date
Application number
PCT/US2000/041606
Other languages
French (fr)
Other versions
WO2001034018A3 (en
Inventor
Lee Weng
David Perozek
Jimin Zhang
Joseph Eichinger
Original Assignee
Therus Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therus Corporation filed Critical Therus Corporation
Priority to JP2001536034A priority Critical patent/JP2003513691A/en
Priority to CA002387127A priority patent/CA2387127A1/en
Priority to AU26193/01A priority patent/AU2619301A/en
Priority to EP00989717A priority patent/EP1229839A4/en
Publication of WO2001034018A2 publication Critical patent/WO2001034018A2/en
Publication of WO2001034018A3 publication Critical patent/WO2001034018A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/44Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
    • A61B8/4422Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to hygiene or sterilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia
    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10KSOUND-PRODUCING DEVICES; METHODS OR DEVICES FOR PROTECTING AGAINST, OR FOR DAMPING, NOISE OR OTHER ACOUSTIC WAVES IN GENERAL; ACOUSTICS NOT OTHERWISE PROVIDED FOR
    • G10K11/00Methods or devices for transmitting, conducting or directing sound in general; Methods or devices for protecting against, or for damping, noise or other acoustic waves in general
    • G10K11/18Methods or devices for transmitting, conducting or directing sound
    • G10K11/26Sound-focusing or directing, e.g. scanning
    • G10K11/32Sound-focusing or directing, e.g. scanning characterised by the shape of the source
    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10KSOUND-PRODUCING DEVICES; METHODS OR DEVICES FOR PROTECTING AGAINST, OR FOR DAMPING, NOISE OR OTHER ACOUSTIC WAVES IN GENERAL; ACOUSTICS NOT OTHERWISE PROVIDED FOR
    • G10K11/00Methods or devices for transmitting, conducting or directing sound in general; Methods or devices for protecting against, or for damping, noise or other acoustic waves in general
    • G10K11/18Methods or devices for transmitting, conducting or directing sound
    • G10K11/26Sound-focusing or directing, e.g. scanning
    • G10K11/34Sound-focusing or directing, e.g. scanning using electrical steering of transducer arrays, e.g. beam steering
    • G10K11/341Circuits therefor
    • G10K11/346Circuits therefor using phase variation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • A61B2017/00504Tissue welding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00641Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closing fistulae, e.g. anorectal fistulae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00902Material properties transparent or translucent
    • A61B2017/00907Material properties transparent or translucent for light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/062Measuring instruments not otherwise provided for penetration depth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/378Surgical systems with images on a monitor during operation using ultrasound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3937Visible markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/16Details of sensor housings or probes; Details of structural supports for sensors
    • A61B2562/164Details of sensor housings or probes; Details of structural supports for sensors the sensor is mounted in or on a conformable substrate or carrier

Definitions

  • the present invention generally relates to methods and apparatus for sealing vascular punctures and wounds, and more particularly, to a device that may be used to deliver ultrasound energy to a vascular puncture site to arrest bleeding.
  • a small gauge needle is introduced through the skin and into a target blood vessel, often the femoral artery.
  • the needle forms a puncture through the blood vessel wall at the distal end of a tract that extends through the overlying tissue.
  • a guide wire is then introduced through the bore of the needle, and the needle is withdrawn over the guide wire.
  • An introducer sheath is next advanced over the guide wire; the sheath and guide wire are left in place to provide access during subsequent procedure(s). The sheath facilitates passage of a variety of diagnostic and therapeutic instruments and devices into the vessel and its tributaries.
  • Illustrative diagnostic procedures include angiography, intravascular ultrasonic imaging, and the like; exemplary interventional procedures include angioplasty, atherectomy, stent and graft placement, embolization, and the like.
  • exemplary interventional procedures include angioplasty, atherectomy, stent and graft placement, embolization, and the like.
  • the catheters, guide wire, and introducer sheath are removed, and it is necessary to close the vascular puncture to provide hemostasis and allow healing.
  • the most common technique for achieving hemostasis is to apply hard pressure on the patient's skin in the region of the tissue tract and vascular puncture to form a blood clot. Initially, pressure is applied manually and subsequently is maintained through the use of mechanical clamps and other pressure-applying devices.
  • Renewed bleeding through the tissue tract is not uncommon and can result in hematoma, pseudoaneurisms, and arteriovenous fistulas. Such complications may require blood transfusion, surgical intervention, or other corrective procedures. The risk of these complications increases with the use of larger sheath sizes, which are frequently necessary in interventional procedures, and when the patient is anticoagulated with heparin or other drugs.
  • Nos. 5,707,393; 5,810,884; 5,649,959; and 5,350,399 provides for the use of small dissolvable disks or anchors that are placed in the vessel to block or clamp the puncture hole.
  • any device remaining in the vessel lumen increases the risk of thrombus formation.
  • Such a device also can detach and cause occlusion in a distal blood vessel, which would likely require major surgery to remove.
  • the method and apparatus should cause rapid cessation of bleeding, not rely on blood clot formation, and should be independent of the patient's coagulation status.
  • the patient will be more comfortable as a result of shortened hemostasis and ambulation times, and physician and hospital resources will thereby be minimized.
  • the method and apparatus should not leave any foreign object in the patient's body, to reduce the risk of stenosis at or distal to the puncture wound.
  • An ideal device will be noninvasive and should not include any component that must be inserted in the catheter tract and which might further damage the wound and impede the sealing process.
  • a method and apparatus are defined that provide advantageous solutions to the problem of expeditiously and safely sealing vascular catheter entry wounds made in connection with medical procedures.
  • the method includes the steps of determining a site of the puncture in the vascular vessel and positioning an ultrasonic transducer applicator at a position adjacent to the site.
  • the ultrasonic transducer applicator is coupled to a control that includes a processor programmed to administer ultrasonic energy in a manner that efficaciously seals a puncture.
  • a user is enabled to initiate a process that is controlled by the control, so that very little operator training is required.
  • the control automatically controls the ultrasonic transducer applicator so that the ultrasonic energy produced by the ultrasonic transducer applicator is focused at the site and is administered at a sufficient intensity and duration to denature tissue at the puncture, closing and sealing the puncture.
  • an imaging ultrasonic beam is generated with the ultrasonic transducer applicator and is transmitted into the patient, proximate an expected location for the site.
  • a reflection of the imaging ultrasonic beam is then received from within the patient using the ultrasonic transducer applicator, producing a corresponding output signal.
  • the output signal is processed with the processor included in the control to facilitate determining the site of the puncture.
  • a visual indication of a location of the site of the puncture can be provided to enable an operator to position the ultrasonic transducer applicator so that the ultrasonic energy produced by the ultrasonic transducer applicator is directed at the site.
  • a visual indication may be in the form of, for example, lighted display indicators.
  • the visual indication includes an image of the site in which an axis of the vascular vessel is visually evident, enabling the operator to position the ultrasonic transducer applicator longitudinally along the axis of the vascular vessel so that the ultrasonic energy is directed at the site of the puncture.
  • an object is provided that extends into the puncture from outside the patient.
  • the operator can then estimate the location of the puncture along the longitudinal axis of the vessel based upon a disposition of the object extending outside the patient.
  • the visual indication includes an image of the site in which the object extending into the puncture is evident. An estimate is made of the location of the puncture based upon a disposition of the object in the image.
  • the output signal can be processed with the processor to determine the site of the puncture.
  • An indicator disposed on the ultrasonic transducer applicator can be controlled by the processor to provide an indication of a direction in which the ultrasonic transducer applicator should be moved to position it adjacent to the site of the puncture.
  • the processor is preferably used for automatically controlling at least one of a direction, an intensity, and a focus of the ultrasonic energy, to ensure that the ultrasonic energy is administered to the site of the puncture.
  • the ultrasonic energy is directed so as to overscan the site of the puncture, ensuring that the puncture is closed and sealed.
  • the processor can move the focus of the ultrasonic energy while it is being administered, to overscan the site of the puncture.
  • an ultrasound emitter of the ultrasonic transducer applicator has an aspheric shape so that the ultrasonic energy that is directed at the site of the puncture covers a larger area that overscans the site.
  • Other transducer configurations that provide a laterally broadened focal region may also be employed.
  • the ultrasonic transducer applicator uses a common array of transducers for generating both the imaging ultrasound beam and the ultrasound energy that closes and seals the puncture. It is also contemplated that the administration of the ultrasonic energy be interrupted, to again generate the imaging ultrasound beam, thereby confirming whether the ultrasonic energy is being directed at the site of the puncture.
  • the processor is preferably employed to control a force applied against a surface of the patient using a force generator included in the ultrasonic transducer applicator. This force is controlled so that a pressure developed by the force is sufficient to substantially stop fluid leakage from the vascular vessel, but not so great as to substantially occlude fluid flow through the vascular vessel.
  • Another aspect of the invention is directed to enclosing the unit applicator within a protective, acoustic coupling shell.
  • the protective, acoustic coupling shell is adapted to contact an external dermal portion of the patient in order to convey the ultrasonic energy transdermally to the site of the puncture, while isolating an ultrasonic emitter surface on the ultrasonic transducer from direct, contacting exposure to the patient.
  • the protective, acoustic coupling shell is preferably pre-sterilized and preferably includes a gel patch on an outer surface that is protected by a tab. The tab is removed prior to contacting the external dermal surface of the patient.
  • Still another aspect of the present invention is directed to apparatus.
  • the apparatus include elements that carry out functions generally consistent with the steps of the method discussed above.
  • FIGURE 1 is a schematic block diagram of the primary components employed in a preferred embodiment of the present invention
  • FIGURE 2 is a schematic diagram illustrating how the present invention is employed for sealing a puncture in a vessel
  • FIGURE 3 schematically illustrates a collagen seal produced by the present invention to close the puncture in the vessel of FIGURE 2;
  • FIGURE 4 is a flow chart illustrating the logical steps followed during sealing of a vascular wound in accord with the present invention;
  • FIGURE 4A is a flow chart illustrating the optional steps employed for detecting nerves during the method of FIGURE 4;
  • FIGURE 5 is a cross-sectional view of a portion of a patient's body, illustrating an applicator unit in accord with the present invention disposed adjacent to a puncture that extends transdermally into an artery;
  • FIGURE 6 is a cutaway isometric view of the applicator shown in FIGURE 5;
  • FIGURE 6A is an isometric view showing the force sensing transducer, force generator, and ultrasonic array of the applicator;
  • FIGURE 7 is an elevational view of a locator rod adapted to be inserted into a puncture wound over a guide wire;
  • FIGURE 7A is a cross-sectional view of a portion of a patient's body like that in FIGURE 5, illustrating the locator rod of FIGURE 7 being used to determine a location of a puncture in the artery relative to the applicator unit;
  • FIGURE 7B is similar to FIGURE 7A, but illustrates the use of ultrasonic pulse-echo techniques to determine the spatial location of the locator rod;
  • FIGURE 7C depicts a view of a framed two-dimensional image a target region generally orthogonal to that shown in FIGURE 7 A and FIGURE 7B, for use in locating the puncture site;
  • FIGURE 8 is a schematic isometric view of an embodiment of the applicator that uses a disposable shell
  • FIGURE 8 A is an side view of the disposable shell of FIGURE 8;
  • FIGURE 9 is a schematic system block diagram depicting modules included in the applicator and control unit.
  • FIGURES 10 and 10A respectively illustrate the ultrasound beam orientation relative to the vessel from the side of the vessel and as viewed along the vessel;
  • FIGURE 1 1 is a plan view of an embodiment of the applicator illustrating the controls and indicators that it includes;
  • FIGURES 12 and 12A respectively illustrate the side and longitudinal geometry of the therapeutic ultrasound beam
  • FIGURE 13 is an isometric view illustrating the ultrasound beam geometry produced by an aspheric transducer.
  • Ultrasound for Sealing Punctures Because of its unique properties in soft tissue, ultrasound can be brought to a tight focus at a distance from its source. If sufficient energy is radiated within the ultrasound beam, cells located in the focal volume can be rapidly heated, while intervening and surrounding tissues are spared. Surrounding tissues are unaffected in the unfocused portion of the ultrasound beam because the energy is spread over a conespondingly larger area and associated heating is minimized.
  • intensities on the order of 0.1 Watts/cm 2 are employed in diagnostic imaging applications, intensities in excess of 1 ,000 Watts/cm 2 are typical in high-intensity focused ultrasound (HIFU) applications. At the focal point, these high intensities result in large, controlled temperature rises within a matter of seconds.
  • HIFU high-intensity focused ultrasound
  • HIFU can rapidly seal blood vessel punctures and lacerations over a wide range of sizes.
  • ultrasound has been shown to induce complete hemostasis in less than one minute in the femoral, carotid, and axillary arteries, and in the femoral and jugular veins of large animals, while blood flow through the treated vessels remained unaffected.
  • FIGURES 1 and 2 show the main components of an ultrasonic system suitable for use in implementing the present invention.
  • a hand-held applicator unit 2 is positioned over an arterial wound 8 in the patient.
  • a generally single-use, pre-sterilized cover and acoustic coupling shell 4 that slips over applicator 2.
  • a control unit 6 implements algorithms to facilitate the method and is coupled to applicator 2.
  • the user enters various conventional scan and control parameters into an input unit 70, which typically includes user input devices 72. Examples of such devices include a keyboard, knobs, and buttons.
  • the input unit is connected to a processing system 74, which will typically comprise a plurality of microprocessors and/or digital signal processors. Processing system 74 may, however, also be implemented using a single processor of sufficient speed to handle the various tasks described below.
  • a conventional memory 75 will normally be included in the system to store, among other data, transmission control parameters and imaging data generated in any given implementation of the present invention.
  • Control circuit 76 forms a transmit ultrasonic waveform by generating and applying electrical control and driving signals to an ultrasound transducer 78, which preferably comprises an array of individually controllable piezoelectric elements.
  • an ultrasound transducer 78 which preferably comprises an array of individually controllable piezoelectric elements.
  • the piezoelectric elements generate ultrasonic waves when electrical signals of a proper frequency are applied to them; conversely, when receiving reflected ultrasonic waves, they generate electrical signals corresponding to the mechanical vibrations caused by the returning ultrasonic waves.
  • Transducer 78 is positioned against a portion 82 of the body of a patient, and by varying the phasing, amplitude, and timing of the driving signals for the transducer anay elements, ultrasonic waves are focused to form a transmit beam 314 of high-intensity ultrasound.
  • open anows indicate the direction of a flow of blood within a blood vessel 312, which has a puncture site 316 that may have been caused by introduction of a catheter or, in the case of unintended punctures that have produced wounds, by some other object.
  • the tissue forming a layer 318 of collagen found on the surface of blood vessels is also shown in FIGURE 2 sunounding blood vessel 312.
  • an imaging capability including pulse-echo lines of interrogation that are not displayed as images, in the present invention should assist a user to more accurately locate a vascular puncture site. It is recognized that a full display of the insonified vascular target site is not required.
  • FIGURE 2 also illustrates a reception controller 78, which will include conventional amplification and signal conditioning circuitry as needed.
  • Reception controller 88 all or part of which is normally integrated into processing system 74, converts the ultrasonic echo signals (which are typically at radio frequencies, on the order of a few to tens of megahertz) into lower frequency ranges for processing and may also include analog-to-digital conversion circuitry.
  • the processing includes, as needed, such known signal conditioning as time-gating, gain compensation, Doppler frequency shift processing, and diffraction compensation, in order to identify echo signals from any selected focal region.
  • the type of conventional signal processing needed (if any) will in general depend on the particular implementation of the present invention employed and can be implemented using known design methods.
  • the transducer 78 be used externally, relative to the patient's body. It is also contemplated that the transducer may be maneuvered inside a patient's body, and the beam focused on a puncture from inside the body.
  • a transesophageal probe, laparoscopic, or other probe inserted into a body cavity, such as the vagina or rectum can be used to practice the present invention.
  • a suitably designed probe inserted into an open body cavity or via minimally invasive means could be used to arrest bleeding in surgical or trauma care situations.
  • most of the following discussion is directed to a preferred embodiment of the present invention in which the transducer is intended to be used externally, since an initial commercial product in accord with the present invention will be designed for such use.
  • a conventional display system 92 may also be included in order to display information concerning transmission power, time, focus data, etc.
  • the display system will include known circuitry for scan conversion and for driving the display, as needed. These circuits are well known and therefore need not be specifically illustrated or described further to provide an enabling disclosure.
  • FIGURE 3 illustrates the result of an insonification of puncture site 316 using the present invention. As the focal point of transmit beam 314 (see
  • FIGURE 2 is moved around (as illustrated by the arrows pointing in either direction from the focus of the beam) the area of puncture site 316 using conventional beam-steering techniques, the tissue adjacent the puncture site 316 will denature.
  • the collagen in the tissue "melts” and flows over and into the puncture opening.
  • the collagen cools, it forms a "patch” that not only covers the puncture, but also flows partially into the puncture opening in the wall of the blood vessel.
  • the denatured tissue tends to contract, it also tends to pull the edges of the puncture together and thus further close the wound.
  • the present invention can be employed to seal vascular wounds of various types and is not limited to the type of wound created as a result of interventional procedures in which a catheter has been introduced into a vascular vessel.
  • application of thermal treatment to the tissue overlying a wound has been demonstrated to seal the wound.
  • a practical method has been developed for repeatedly and reliably achieving sealing of the puncture in a vascular vessel. Steps carried out in this method are shown in FIGURE 4, which is discussed below. These steps represent one prefened embodiment of the present invention, but do not represent all alternatives that might be employed to achieve acceptable sealing.
  • Key steps in the method for vascular sealing described here include: 1. Positioning an ultrasound generating source on a patient such that the source is targeted at an area including the wound to be sealed; 2. Applying a pressure against the patient in an area overlying the wound and directed substantially toward the vessel to be treated;
  • a clinically acceptable device for sealing a puncture wound in accord with the present invention must meet a number of requirements, including:
  • the device and associated procedure must be safe to use in that they avoid undesirable bioeffects, so that the patient is not injured directly or indirectly as a result of the procedure; also, in the event that effective vessel sealing does not occur as desired, traditional methods of applying pressure to the wound are sufficient to accomplish hemostasis;
  • the device and associated procedure must be easy to use in an efficient manner, to facilitate proper, repeatable execution of the sealing process; requirements for operator training should be minimized;
  • the sealing process must be sufficiently fast to enable the entire procedure to be rapidly completed - preferably, in less than 5 minutes;
  • the efficacy of the device should be very high, generally achieving a success rate in excess of about 95%; acceptability of the present invention in routine clinical practice does not permit an unpredictable outcome.
  • a preferred embodiment of the device includes the components shown in FIGURES 1 and 2, which were described above.
  • FIGURE 6 and FIGURE 6A show one prefened embodiment of applicator unit 2.
  • the applicator unit includes an outer housing 10 having an ergonomically considered shape so that it can be conveniently hand held.
  • the outer housing is best fabricated from an injection moldable plastic material such as ABS or the like.
  • the operator grasps the outer housing of the applicator unit so as to enable a control push- button 14 to be accessible and indicators 12, 16 and 30, 32, 34, and 36 to be visible to the operator. Positioning the applicator unit at the appropriate location over the wound area and activation of an essentially automated treatment cycle are readily accomplished. The operator simply refers to the indicators to determine when the applicator unit is properly positioned and ready for use.
  • Indicators 12 and 16 are used to indicate when alignment of the applicator unit with the longitudinal axis of the vessel to be sealed has been achieved.
  • Indicators 30, 32, 34, and 36 display the state of operation and instruct the operator with respect to holding the applicator in place as described in detail later in this description.
  • Control 14 when pressed, activates the treatment cycle, thus initiating a sequence of operations that determine ultrasonic scan parameters (exposure time, scan pattern, intensity, focal range, etc.).
  • ultrasonic array assembly 20 is held within outer housing 10 on a shaft 40, in a bearing assembly within a force transducer 18, so as to permit movement of the ultrasonic array assembly to and away from patient 8.
  • Shaft 40 passes through the bearing assembly provided within a force generator 18 and terminates at a contacting force sensing transducer 42.
  • Force generator 18 comprises an electromagnetic solenoid that is rigidly supported and mounted within housing 10 by structural members 46. The face of ultrasonic array assembly 20 is in contact with the appropriate location on the body of the patient (overlying the site of the puncture) and is thus capable of applying a substantially compressive, controllable force on the tissue structures with which it is in contact.
  • the force applied by the ultrasonic array assembly is produced at least in part by controllably energizing force generator 18.
  • Ultrasonic array assembly 20 preferably operates in a multiplicity of modes; however, separate ultrasonic transducers can instead be provided for some or all of the functions performed in a different design within the scope of the present invention.
  • electrical connections comprising wires 26 are routed within the outer housing 10 and out in a sealed bushing 44 that mounts a cable 28 to the control unit 6.
  • Cable 28 is sufficiently long, on the order of 10 feet in length, so that the control unit may be conveniently located at a distance from the patient and operator location.
  • Applicator unit housing 10 is shaped to be used with a slip-on, generally single-use protective applicator shell 4 (illustrated schematically in FIGURE 1).
  • the shell employed in the preferred embodiment is shown in greater detail in FIGURES 8 and 8A.
  • Shell 4 has side walls 54 that are fabricated from a generally optically transparent, semi-rigid plastic material.
  • a skirt 52 extends from the rear of the shell and is pleated so that in preparing for use of the applicator unit, an operator can grasp the skirt and extend it sufficiently to protect a sterile area of the patient from coming into contact with cord.
  • the protective shell is packaged in a sterile condition.
  • the shell is fabricated from a flexible plastic material having low acoustic abso ⁇ tion characteristics.
  • a fiducial mark 56 is provided on a side of the applicator unit and visible through the optically transparent material of the protective shell. This fiducial mark is employed to visually align the applicator unit with a position on the patient at which the applicator unit will be used to seal a puncture.
  • Sterile, generally gas free acoustic coupling gel 62 is deposited in a patch on the bottom of flexible bottom 58. Prior to use, the gel is held in place and sealed by semi-sticky adhesive coated tab 60. Tab 60 is removed by the operator just prior to use, thereby exposing the gel so that it provides a good acoustic coupling with the surface of the patient's body.
  • Protective applicator shell 4 thus provides a sterile barrier over the multi-use applicator unit and conveniently provides a pre-determined amount of a specific appropriate acoustic coupling medium.
  • the bottom of the interior cavity of the shell may also include a layer of acoustic coupling gel to ensure good acoustic coupling between the applicator unit through the protective, applicator coupling shell.
  • FIGURE 9 is a system block diagram illustrating the modules disposed, in the preferred embodiment, within the applicator unit 2 (i.e., the component shown within the dotted line portion of this Figure) as well as the modules (all other modules that are not in the applicator unit) disposed in the control unit 6.
  • control unit 6 is packaged in a small, self-contained pole- or cart-mounted enclosure that derives its input power from a standard AC line power service (not shown). Power supplies with the unit are designed to assure low leakage currents for patient safe operation.
  • control unit 6 is based on a programmable processing unit which processes various signals and controls a number of functional modules.
  • a microprocessor is well suited to perform the computation and control functions required.
  • Applicator unit 2 is coupled to control unit 6 by a plurality of signal paths 212, 214, 216, and 218.
  • Signal path 212 couples display drivers 200, which are controlled by a computer/controller 236, with indicators 30, 32, 34, and 36 on the applicator unit.
  • Control button 14 on the applicator unit is coupled through signal line 214 to an interface 202 and thus to the computer/controller.
  • Force sensing transducer 42 produces an output signal indicative of the force (i.e., the pressure) applied against the surface of the patient's tissues by the applicator unit, and this signal is conveyed by signal lines 216 to an interface 204, which provides the signal to the computer/controller.
  • the computer/controller In response to the magnitude of the monitored force, the computer/controller produces a control signal applied to a driver 206, which provides the current signal used to energize force transducer 16, to determine any additional force that it generates to achieve a desired pressure on the site of the puncture that is sufficient to prevent loss of fluid from the vessel, but not so great as to occlude the flow of fluid through the vessel.
  • Signal lines 240 couple ultrasonic anay assembly 20 to a transmit/receive switch 224.
  • the transmit/receive switch determines the operational mode of the ultrasonic anay assembly under the control of the computer/controller.
  • the signal corresponding to the echo reflected received by ultrasonic array assembly 20 from tissue and other structures is conveyed through transmit/receive switch 224 and through signal lines 222 to an amplifier digitizer anay 220.
  • the output signals from the amplifier digitizer array are conveyed to computer/controller 236 through signal lines 228.
  • the ultrasonic array assembly When the ultrasonic array assembly is generating either the imaging beam or the HIFU beam, it is responding to signals received from an RF generator 232 that is coupled to a phase shift/amplifier array 234 by signal lines 236, and to a control signal provided by the computer/controller and conveyed to the phase shift/amplifier on a signal line 230.
  • the output of the phase shift/amplifier is conveyed on signal lines 226 to transmit/receive switch 224, and thus, to ultrasonic array assembly 20 through signal lines 240.
  • Manual control inputs 241 are coupled to computer/controller 236 through signal lines 242.
  • Possibilities include: • Configurations wherein therapeutic and, pulse-echo Doppler functionality are accomplished by the same ultrasonic transducer or by separate ultrasonic transducers; and,
  • the ultrasonic transducer is either of a fixed focus type, or a segmented electrically selectable macro element array, or a phased array, or a linear array, or an annular anay; and,
  • a large focal spot 412 e.g. a focal spot produced by a transducer having an aspheric shape, or those in which a tightly focused spot is produced;
  • An aspheric ultrasonic transducer configuration has the advantage of covering a large treatment area on the surface of the vessel without the complication of electronic or mechanical beam steering. Covering a large area (i.e., overscanning) is desired in order to ensure that the actual site of the puncture wound is treated, given its positional ambiguity.
  • FIGURE 13 depicts the geometry of such a configuration.
  • an ultrasonic transducer 404 excited by an appropriate RF source via connections 402, is generally aspheric in shape and does not bring the ultrasound beam to a sha ⁇ focus. The ultrasonic energy that it produces covers area 412 on a vessel 408 that includes puncture wound 410.
  • Fluid or solid material acoustic coupling (not shown) is used between the ultrasonic transducer and the tissues of the patient.
  • the method described includes a series of manual steps (operator actions) and automated steps.
  • the automated steps are carried out as control processes or algorithms executed by one or more processors and other hardware in accord with machine instructions executed by the one or more processors. It is understood that variations in the order of these steps, and in the total complement of steps implemented is possible in alternative embodiments. Steps as shown in FIGURE 4 are described as follows.
  • a step 100 labeled Patient Preparation the operator positions the patient and the apparatus so that the applicator unit is conveniently positioned over the puncture wound area, e.g., over the puncture made by a catheter in the femoral artery.
  • Shell 4 is removed from its sterile package and fitted onto applicator unit 2, and gel sealing tab 60 (shown in FIGURES 8 and 8A) is removed, exposing the gel 62.
  • a step 102 labeled Manually Align is then carried out.
  • the operator palpates the area locating the point at which the introducer just enters the artery.
  • the operator marks this location on the patient's skin with a suitable marking device (e.g. a surgical marker), drawing a line substantially pe ⁇ endicular to the perceived direction of the artery, extending approximately 3 cm from the entry wound location. It is the pu ⁇ ose of this marking to estimate the longitudinal location of the wound; the operation of the HIFU sealing process provides for an overscan of the wound area so that practical variations in the operator's ability to make the longitudinal position estimate are permissible. Other techniques for locating the site of the puncture are discussed below.
  • lateral and range locations of the wound are more precisely located by the automated capability of the processor(s) used in the apparatus.
  • step 102 the operator places the device over the wound location, aligning fiducial mark "56" (shown in FIGURE 8) with the line that was drawn on the patient's skin.
  • the applicator unit is rotated in place until both alignment indicators 12 and 16 (FIGURES 6 and 8) illuminate, indicating that the artery is axially aligned under the applicator unit.
  • the axial alignment indications are, in this preferred embodiment, derived from two ultrasonic pulsed Doppler interrogations.
  • FIGURES 10 and 10A show the geometry of the Doppler alignment beams. Use of a ultrasonic transducer 20 enables the same ultrasonic transducer to be employed to produce an imaging beam and the HIFU beam for both a pulse-echo targeting mode and a therapeutic mode.
  • phased array ultrasonic transducer 20 sends and receives a downstream pulsed Doppler line 304 and an upstream line 308 sequentially. Lines 304 and 308 are in plane with the axial centerline of the applicator unit and a line pe ⁇ endicular to the bottom surface of the applicator unit.
  • Lines 304 and 308 are transmitted at angles A and B with respect to a line 306, which is pe ⁇ endicular to the applicator unit. Angles A and B are chosen to provide a axial separation as well as an appreciable vector flow component in the direction of the interrogating line - an angle of approximately 45 degrees. Direction of flow in an interior 310 of the vessel is sensed and tested to assure that an artery 300 (not a vein) is being interrogated. Doppler signals, from lines 304 and 308, integrated over an appropriate range, above a pre-determined threshold value, are used to cause the illumination of alignment indicators 12 and 16 respectively. Averaging multiple lines is, in this prefened embodiment, employed to improve the performance of the alignment detection scheme. The conditioned signals also set logical flags so that the system may interlock the initiation of a therapeutic treatment sequence with assurance of alignment. Thus in a decision step 106 (FIGURE 4), alignment is tested by interrogating the logical presence of both of the flags.
  • FIGURE 1 1 illustrates a top view of the applicator unit.
  • FIGURE 1 1 illustrates a top view of the applicator unit.
  • three parallel lines are transmitted and received in the two directions indicated by lines 304 and 308 in FIGURE 10.
  • Additional transducers are appropriately positioned in housing 10 (FIGURE 6).
  • Pulsed Doppler signals are processed in a manner similar to that described above.
  • indicator lights 336 and 334 would be illuminated, indicating the misalignment and suggesting the appropriate direction to move the applicator unit to achieve align ent (denoted when indicators 338 and 330 are illuminated).
  • continuous wave Doppler may be employed to interrogate the flow position of the target artery, with operation essentially similar to that described above.
  • step 106 the system proceeds to a step 108 labeled Set Pressure, wherein the pressure over the artery is set and controlled within a predetermined range using force generator 18 (FIGURE 6) and force sensing transducer 42.
  • the weight of the applicator unit is pu ⁇ osefully made to be in a range where additional pressure applied by the operator to hold the unit firmly in place is reduced. This useful weight is about 1 lb (0.45 kg) or more.
  • Force generator 18 is activated and controlled such that applied pressure to the artery partially restricts flow, but maintains sufficient flow so that thermal cooling due to blood flow within the artery protects the intimal lining of the vessel from irreversible damage.
  • Presence of a Doppler flow signal on down-stream line 304 is employed to assure vessel patency.
  • indicator 32 which is marked “READY” on the applicator unit is illuminated (see block 1 18 FIGURE 4), indicating to the operator that a treatment cycle may be manually initiated (triggered) by pushing control button 14.
  • the system is in a wait state as indicated in a decision block 1 12 in FIGURE 4, until a manually triggered treatment cycle is detected.
  • axial alignment is verified in a step 1 14 by generally repeating the logical test described at step 102.
  • a step 1 16 then makes a ranging measurement to estimate the acoustic path length between ultrasonic transducer assembly 20 and the vessel boundary, i.e., the distance between points F and C along line 306 in FIGURE 10.
  • Pulsed Doppler is, in this preferred embodiment, employed to make this measurement, wherein lines 304 and 308 measure distances F-D and F-E, respectively. Points D and E are recognized by the fact that these correspond to the first instance of flow detected along each line as range increases.
  • the range estimate of FC is therefore:
  • a step 120 estimates the acoustic attenuation at the therapeutic frequency between ultrasonic transducer assembly 20 and the target collagen layer overlaying the vascular wound, path F-C in FIGURE 10.
  • estimated dimension FC is used to access data in a look-up table of attenuation values. Attenuation values in the table are predetermined by empirical measurement. Alternatively, more sophisticated A-Mode attenuation measurements may be employed to assess to F-C path.
  • a step 122 determines the therapeutic ultrasound exposure parameters to be employed.
  • Dimension F-C, the attenuation estimate, and optionally, patient parameters (e.g., size and weight), input at module 240 in FIGURE 9, are used to access predetermined data and scan protocols in resident look-up tables Ultrasound scan geometry, intensity and epochal exposure intervals are thus determined.
  • Ultrasound scan geometry, intensity and time parameters are determined to accomplish three key objectives: (1 ) provide a sufficient overscan of a longitudinal and lateral surface of the target vessel so as to include the site of the wound; (2) ensure delivery of an appropriate energy dose to the collagen layer in the region of the target site to raise its temperature to a range of between 60 and 100 degrees Celsius for a predetermined period of time; and, (3) assure that the skin and inte ⁇ ath tissue is not exposed to a temperature-time exposure that will result in pain and or irreversible tissue damage.
  • Therapeutic scan geometry is shown in FIGURES 12A and 12B.
  • a therapeutic level of approximately 50 watts total transmitted acoustic power, generally weakly focused, is transmitted along a centerline 314 through a dermal layer 302.
  • the desired scan pattern is achieved by directing the beam over varying angles of the beam with respect to a line 320 that extends pe ⁇ endicular to the center of the face of the application unit.
  • a raster scan pattern may cover a therapeutic area, over collagen layer 318, of dimensions 1 cm wide by 1.5 cm long ( in the arterial axial direction).
  • Such an overscan of the wound site provides for variations in the operator's ability to predetermine and locate the precise lateral position of the wound, as well as the variation in wound location that results from the possible variation of wound lateral entry points.
  • scan geometry is selected such that ultrasonic exposure is generally confined to the vessel, minimizing the possibility that an adjacent vein or nerve structure will be insonified.
  • a step 126 carries out the therapeutic exposure cycle. It is generally desirable to hold the applicator unit in place, providing the established orientation and pressure for a period of time after the therapeutic exposure cycle.
  • a hold interval 130 (FIGURE 4) is selected to enable exposed tissue structures to cool, a time period of approximately 1 minute. Following this time period, indicator 36 on the application unit (FIGURE 6) marked “COMPLETE” is illuminated and the "HOLD" indicator is turned off, instructing the operator that the therapeutic treatment is completed and the device may be removed from the patient.
  • FIGURE 4A An additional sequence depicted in FIGURE 4A may optionally be employed.
  • the sequence is inserted into the process flow of FIGURE 4, in this prefened embodiment, at a location marked "A.”
  • a weak, sub-therapeutic energy level ultrasonic pulse is transmitted in a step 136 (FIGURE 4A), to cover the determined target area.
  • the operator observes in a decision step 138 whether a reaction of pain and or uncommanded movement from the patient has occurred, indicating that a nerve structure has been stimulated.
  • System logic then waits for an addition manually initiated trigger input in steps 140 and 142, prior to proceeding with therapeutic exposure at step 126 in FIGURE 4.
  • Alternative Techniques for Aligning the Applicator unit Step 102 which facilitates alignment of the applicator unit over the wound area and targeting of the therapeutic exposure, may be accomplished using several alternative approaches compared to that described above. It is desired to employ an approach for targeting and aligning the applicator unit that is easy to implement and requires minimum operator instruction. The approach further should be consistent with minimizing bleeding during the process of achieving alignment. Additionally, the approach should be robust and provide targeting of the wound site with sufficient accuracy such that the wound will reliably be included within the area of therapeutic exposure.
  • a principle employed in the present invention is the concept that the overscan of the target location during therapeutic exposure is sufficient to accommodate targeting ambiguity and possible patient or operator movement during the procedure. Nevertheless, accurate targeting is needed to ensure efficacy of the wound sealing process.
  • FIGURE 5 illustrates the geometry that relates the location of applicator unit 2 to the locations of an entry channel 518 and a vessel wound 516.
  • applicator unit 2 is positioned on a patient's skin surface 510 over a vessel 506 in which a blood flow 508 is contained.
  • a location “C” is indicated at wound 516; a line 512 passes from “C” through entry channel 518, intersecting a plane 514 defined by reference locations on applicator unit 2 at a point “H.”
  • a point “F” is a reference point in plane 514. If the spatial location of line 512 is known relative to plane 514 and point “F,” and the vector distances "H” to “F", or “C” to “F” are known, then the location of wound 516 relative to applicator unit 2 is determinable by basic geometry. Knowledge of this geometry permits automated system function to be employed to provide guidance instructions (e.g. visual indicators) to the operator during the manual alignment portion of the procedure.
  • guidance instructions e.g. visual indicators
  • acoustic pulsed Doppler may be employed to determine the distance "C" - “F” (reference FIGURE 5).
  • the vessel is an artery having a substantial high velocity flow and is thus readily localized using well known pulsed Doppler techniques. Knowing this distance, localization of wound 516 on the vessel is made possible by determining the spatial position of line 512.
  • the spatial location of line 512 may be determined by employing a substantially rigid, straight locator rod 554 as depicted in FIGURE 7, which is placed in entry channel 518.
  • Locator rod may have a longitudinal center bore 556 through which a guide wire 552 may pass.
  • Locator rod 554 would be introduced into the wound over the guide wire.
  • Sealing assembly 550 is disposed at one end of the locator rod to prevent the loss of blood through center bore 556.
  • a spatial position resolving element 558 may be included on locator rod 554.
  • Spatial position resolving element 558 may be an acoustic position sensor, an optical position sensor, a magnetic position sensor, an electromechanical positioning or resolving arm, or an inertial position sensor. The spatial relationship between the position of al ⁇
  • locator rod 554 and applicator unit 2 is accomplished by either a direct mechanical linkage or by way of an intermediate electronic or computational circuit.
  • an ultrasonic pulse-echo technique may be employed to determine the spatial location of locator rod 554.
  • a transducer in applicator unit 2 transmits directed acoustic pulses in more than one direction, e.g., lines 560, 562, and 564, and echoes from structures in each path are returned and detected by a pulse-echo receiver included in the applicator unit, as is well know in the diagnostic ultrasound art.
  • Locator rod 554 provides reflections that permit making time of flight measurements of, for example, distances "F"-"I,” “F"-"K,” and “F"-”L.”
  • Locator rod 554 may be coated or constructed of materials chosen to enhance acoustic reflectivity, thus providing echoes that are readily distinguished from background clutter.
  • locator rod 554 may be constructed from materials that enhance reflection at a harmonic of the interrogating ultrasound pulse, providing another advantageous method for clearly distinguishing the echoes from locator rod 554 from those received from surrounding tissue. Materials or coatings that entrap gas bubbles are, for example, effective in providing higher harmonic reflection. Echo enhancing properties may also be inco ⁇ orated into an introducer that is then used as the locator rod.
  • Pulsed Doppler may also be employed to identify and locate the locator rod.
  • the locator rod may be a common introducer. A strong Doppler shifted reflection will return from the lumen of the introducer even when blood is not permitted to flow out of the introducer.
  • FIGURE 7C depicts a view of a framed two-dimensional image 580 of the target region generally orthogonal to that shown in FIGURES 7 A and 7B. Distance from the ultrasound source increases toward the bottom of this depiction. This image is generally representative of a cross-sectional plane of interrogation located at a line 562 in FIGURE 7B. Automated image recognition provided by the processor may be employed to identify structures including locator rod 554, imaged as a locator rod structure 586 and vessel 506, imaged as a vessel structure 584 in this image.
  • Doppler imaging and color flow mapping may be employed to increase the recognizablility of relevant features.
  • the interrogating image plane may be scanned over the region containing the target.
  • locator rod structure 586 is recognized at a location just touching the top surface of vessel structure 584, the wound target site has been identified.

Abstract

An ultrasonic applicator unit (2) is used diagnostically to locate a puncture wound (316) in an artery and then therapeutically to seal the puncture wound with high intensity focused ultrasound (HIFU). A control unit (6) coupled to the applicator unit includes a processor (74) that automates the procedure, controlling various parameters of the diagnostic and therapeutic modes, including the intensity and duration of the ultrasonic energy emitted by the applicator unit. A protective, sterile acoustic shell (4), which is intended to be used with a single patient and then discarded, is slipped over the applicator unit to protect against direct contact between the applicator unit and the patient and to maintain a sterile field at the site of the puncture. The apparatus and method are particularly applicable to sealing a puncture made when inserting a catheter into an artery or other vessel.

Description

USE OF FOCUSED ULTRASOUND FOR VASCULAR SEALING
Related Applications
This application is based on prior copending U.S. provisional patent application, Serial No. 60/163,466, filed October 25, 1999, and prior copending U.S. provisional patent application, Serial No. 60/171 ,703, filed
December 23, 1999, the benefit of the filing dates of which is hereby claimed under 35 U.S.C. § 1 19(e).
Field of the Invention The present invention generally relates to methods and apparatus for sealing vascular punctures and wounds, and more particularly, to a device that may be used to deliver ultrasound energy to a vascular puncture site to arrest bleeding.
Background of the Invention
Various surgical procedures are performed by medical specialists such as cardiologists and radiologists, utilizing percutaneous entry into a blood vessel. To facilitate cardiovascular procedures, a small gauge needle is introduced through the skin and into a target blood vessel, often the femoral artery. The needle forms a puncture through the blood vessel wall at the distal end of a tract that extends through the overlying tissue. A guide wire is then introduced through the bore of the needle, and the needle is withdrawn over the guide wire. An introducer sheath is next advanced over the guide wire; the sheath and guide wire are left in place to provide access during subsequent procedure(s). The sheath facilitates passage of a variety of diagnostic and therapeutic instruments and devices into the vessel and its tributaries. Illustrative diagnostic procedures include angiography, intravascular ultrasonic imaging, and the like; exemplary interventional procedures include angioplasty, atherectomy, stent and graft placement, embolization, and the like. After this procedure is completed, the catheters, guide wire, and introducer sheath are removed, and it is necessary to close the vascular puncture to provide hemostasis and allow healing. The most common technique for achieving hemostasis is to apply hard pressure on the patient's skin in the region of the tissue tract and vascular puncture to form a blood clot. Initially, pressure is applied manually and subsequently is maintained through the use of mechanical clamps and other pressure-applying devices. While effective in most cases, the application of external pressure to the patient's skin presents a number of disadvantages. When applied manually, the procedure is time-consuming and requires the presence of a medical professional for thirty minutes or more. For both manual and mechanical pressure application, the procedure is uncomfortable for the patient and frequently requires the administration of analgesics to be tolerable. Moreover, the application of excessive pressure can occlude the underlying artery, resulting in ischemia and or thrombosis. Even after hemostasis has apparently been achieved, the patient must remain immobile and under observation for hours to prevent dislodgment of the clot and to assure that bleeding from the puncture wound does not resume. Renewed bleeding through the tissue tract is not uncommon and can result in hematoma, pseudoaneurisms, and arteriovenous fistulas. Such complications may require blood transfusion, surgical intervention, or other corrective procedures. The risk of these complications increases with the use of larger sheath sizes, which are frequently necessary in interventional procedures, and when the patient is anticoagulated with heparin or other drugs.
In recent years, several hemostasis techniques have been proposed to address the problem of sealing vessel wall punctures following percutaneous transcatheter procedures. Related prior art is described in U.S. Patent Nos. 5,320,639; 5,370,660; 5,437,631 ; 5,591 ,205; 5,830,130; 5,868,778; 5,948,425; 6,017,359; and 6,090,130. In each of these patents, bioabsorbable, thrombogenic plugs comprising collagen and other materials are placed proximal to the vessel wall puncture site to stop bleeding. The large hemostasis plug stimulates blood coagulation in the vessel puncture site, but blocks the catheter entry tract, making catheter reentry more difficult, if required. Other related prior art disclosed in U.S. Patent
Nos. 5,707,393; 5,810,884; 5,649,959; and 5,350,399 provides for the use of small dissolvable disks or anchors that are placed in the vessel to block or clamp the puncture hole. However, any device remaining in the vessel lumen increases the risk of thrombus formation. Such a device also can detach and cause occlusion in a distal blood vessel, which would likely require major surgery to remove.
Additional prior art includes U.S. Patent Nos. 5,779,719; 5,496,332; 5,810,850; and 5,868,762. In the disclosure of these patents, needles and sutures delivered through catheters are used to ligate the puncture. The suturing procedure requires particular skill. Suture material left in the vessel may cause tissue irritation that will prolong the healing process.
Still other prior art is disclosed in U.S. Patent No. 5,626,601, wherein a procoagulant is injected into the puncture, with a balloon catheter blocking inside the vessel lumen. However, in some cases, the clotting agent may leak past the balloon into the vessel lumen and cause stenosis.
Yet other prior art references related to this topic include U.S. Patent Nos. 4,929,246; 5,810,810; and 5,415,657, which disclose the use of a laser or of radio-frequency (RF) energy that is transmitted to the blood vessel through a catheter to thermally fuse or weld the punctured tissue together.
All of the above cited prior art references require either introducing and leaving foreign objects in the patient's body, and/or inserting a tubular probe of large diameter into the tissue channel left by the catheter in order to seal the puncture.
As will be evident from the preceding discussion, there is a clear need for an improved method and apparatus for sealing a puncture left in a blood vessel, following an intravascular catheterization procedure. The method and apparatus should cause rapid cessation of bleeding, not rely on blood clot formation, and should be independent of the patient's coagulation status. By employing such a method and apparatus, the patient will be more comfortable as a result of shortened hemostasis and ambulation times, and physician and hospital resources will thereby be minimized. In addition, the method and apparatus should not leave any foreign object in the patient's body, to reduce the risk of stenosis at or distal to the puncture wound. An ideal device will be noninvasive and should not include any component that must be inserted in the catheter tract and which might further damage the wound and impede the sealing process.
Summary of the Invention In accord with the present invention, a method and apparatus are defined that provide advantageous solutions to the problem of expeditiously and safely sealing vascular catheter entry wounds made in connection with medical procedures. The method includes the steps of determining a site of the puncture in the vascular vessel and positioning an ultrasonic transducer applicator at a position adjacent to the site. The ultrasonic transducer applicator is coupled to a control that includes a processor programmed to administer ultrasonic energy in a manner that efficaciously seals a puncture. A user is enabled to initiate a process that is controlled by the control, so that very little operator training is required. The control automatically controls the ultrasonic transducer applicator so that the ultrasonic energy produced by the ultrasonic transducer applicator is focused at the site and is administered at a sufficient intensity and duration to denature tissue at the puncture, closing and sealing the puncture. To determine the site of the puncture, an imaging ultrasonic beam is generated with the ultrasonic transducer applicator and is transmitted into the patient, proximate an expected location for the site. A reflection of the imaging ultrasonic beam is then received from within the patient using the ultrasonic transducer applicator, producing a corresponding output signal. The output signal is processed with the processor included in the control to facilitate determining the site of the puncture.
For example, a visual indication of a location of the site of the puncture can be provided to enable an operator to position the ultrasonic transducer applicator so that the ultrasonic energy produced by the ultrasonic transducer applicator is directed at the site. Such a visual indication may be in the form of, for example, lighted display indicators. In one form of the present invention, the visual indication includes an image of the site in which an axis of the vascular vessel is visually evident, enabling the operator to position the ultrasonic transducer applicator longitudinally along the axis of the vascular vessel so that the ultrasonic energy is directed at the site of the puncture.
In an alternative embodiment, an object is provided that extends into the puncture from outside the patient. The operator can then estimate the location of the puncture along the longitudinal axis of the vessel based upon a disposition of the object extending outside the patient. As yet a further alternative, the visual indication includes an image of the site in which the object extending into the puncture is evident. An estimate is made of the location of the puncture based upon a disposition of the object in the image.
Finally, the output signal can be processed with the processor to determine the site of the puncture. An indicator disposed on the ultrasonic transducer applicator can be controlled by the processor to provide an indication of a direction in which the ultrasonic transducer applicator should be moved to position it adjacent to the site of the puncture.
The processor is preferably used for automatically controlling at least one of a direction, an intensity, and a focus of the ultrasonic energy, to ensure that the ultrasonic energy is administered to the site of the puncture. Using the processor, the ultrasonic energy is directed so as to overscan the site of the puncture, ensuring that the puncture is closed and sealed. For example, the processor can move the focus of the ultrasonic energy while it is being administered, to overscan the site of the puncture. As another alternative, an ultrasound emitter of the ultrasonic transducer applicator has an aspheric shape so that the ultrasonic energy that is directed at the site of the puncture covers a larger area that overscans the site. Other transducer configurations that provide a laterally broadened focal region may also be employed.
Preferably, the ultrasonic transducer applicator uses a common array of transducers for generating both the imaging ultrasound beam and the ultrasound energy that closes and seals the puncture. It is also contemplated that the administration of the ultrasonic energy be interrupted, to again generate the imaging ultrasound beam, thereby confirming whether the ultrasonic energy is being directed at the site of the puncture.
The processor is preferably employed to control a force applied against a surface of the patient using a force generator included in the ultrasonic transducer applicator. This force is controlled so that a pressure developed by the force is sufficient to substantially stop fluid leakage from the vascular vessel, but not so great as to substantially occlude fluid flow through the vascular vessel.
Another aspect of the invention is directed to enclosing the unit applicator within a protective, acoustic coupling shell. The protective, acoustic coupling shell is adapted to contact an external dermal portion of the patient in order to convey the ultrasonic energy transdermally to the site of the puncture, while isolating an ultrasonic emitter surface on the ultrasonic transducer from direct, contacting exposure to the patient. The protective, acoustic coupling shell is preferably pre-sterilized and preferably includes a gel patch on an outer surface that is protected by a tab. The tab is removed prior to contacting the external dermal surface of the patient.
Still another aspect of the present invention is directed to apparatus. The apparatus include elements that carry out functions generally consistent with the steps of the method discussed above. Brief Description of the Drawing Figures
The foregoing aspects and many of the attendant advantages of this invention will become more readily appreciated as the same becomes better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein: FIGURE 1 is a schematic block diagram of the primary components employed in a preferred embodiment of the present invention; FIGURE 2 is a schematic diagram illustrating how the present invention is employed for sealing a puncture in a vessel;
FIGURE 3 schematically illustrates a collagen seal produced by the present invention to close the puncture in the vessel of FIGURE 2; FIGURE 4 is a flow chart illustrating the logical steps followed during sealing of a vascular wound in accord with the present invention;
FIGURE 4A is a flow chart illustrating the optional steps employed for detecting nerves during the method of FIGURE 4;
FIGURE 5 is a cross-sectional view of a portion of a patient's body, illustrating an applicator unit in accord with the present invention disposed adjacent to a puncture that extends transdermally into an artery;
FIGURE 6 is a cutaway isometric view of the applicator shown in FIGURE 5;
FIGURE 6A is an isometric view showing the force sensing transducer, force generator, and ultrasonic array of the applicator;
FIGURE 7 is an elevational view of a locator rod adapted to be inserted into a puncture wound over a guide wire;
FIGURE 7A is a cross-sectional view of a portion of a patient's body like that in FIGURE 5, illustrating the locator rod of FIGURE 7 being used to determine a location of a puncture in the artery relative to the applicator unit;
FIGURE 7B is similar to FIGURE 7A, but illustrates the use of ultrasonic pulse-echo techniques to determine the spatial location of the locator rod;
FIGURE 7C depicts a view of a framed two-dimensional image a target region generally orthogonal to that shown in FIGURE 7 A and FIGURE 7B, for use in locating the puncture site;
FIGURE 8 is a schematic isometric view of an embodiment of the applicator that uses a disposable shell;
FIGURE 8 A is an side view of the disposable shell of FIGURE 8;
FIGURE 9 is a schematic system block diagram depicting modules included in the applicator and control unit;
FIGURES 10 and 10A respectively illustrate the ultrasound beam orientation relative to the vessel from the side of the vessel and as viewed along the vessel;
FIGURE 1 1 is a plan view of an embodiment of the applicator illustrating the controls and indicators that it includes;
FIGURES 12 and 12A respectively illustrate the side and longitudinal geometry of the therapeutic ultrasound beam; and FIGURE 13 is an isometric view illustrating the ultrasound beam geometry produced by an aspheric transducer.
Description of the Preferred Embodiment
Use of Ultrasound for Sealing Punctures Because of its unique properties in soft tissue, ultrasound can be brought to a tight focus at a distance from its source. If sufficient energy is radiated within the ultrasound beam, cells located in the focal volume can be rapidly heated, while intervening and surrounding tissues are spared. Surrounding tissues are unaffected in the unfocused portion of the ultrasound beam because the energy is spread over a conespondingly larger area and associated heating is minimized.
Whereas ultrasound intensities on the order of 0.1 Watts/cm2 are employed in diagnostic imaging applications, intensities in excess of 1 ,000 Watts/cm2 are typical in high-intensity focused ultrasound (HIFU) applications. At the focal point, these high intensities result in large, controlled temperature rises within a matter of seconds.
It has been demonstrated in numerous in vivo animal studies that HIFU can rapidly seal blood vessel punctures and lacerations over a wide range of sizes. When accurately targeted on a vascular wound, ultrasound has been shown to induce complete hemostasis in less than one minute in the femoral, carotid, and axillary arteries, and in the femoral and jugular veins of large animals, while blood flow through the treated vessels remained unaffected. These investigations included: (a) sealing punctured, surgically exposed vessels using visual targeting, (b) sealing incised, surgically exposed vessels using visual targeting, (c) sealing surgically exposed, punctured vessels using Doppler- guided ultrasound targeting, and (d) noninvasive sealing of punctured vessels under ultrasound imaging guidance wherein complete hemostasis was noted in 13 ± 12 seconds.
The mechanism of hemostasis in these ultrasound-exposed vascular wounds appears thermal in origin and involves denaturization of native perivascular collagen with subsequent formation of an extensive fibrin network that covers the hole, thereby sealing it closed. The fibrin links with adjacent vessel wall tissues to form a seal that has been shown to be independent of puncture hole size. Acoustic streaming forces generated by the HIFU beam were also observed to play a role in opposing the escape of blood from the vascular wound. Blood clotting is not believed to be a factor in achieving acoustic hemostasis, as evidenced by equally rapid and complete wound sealing in highly anticoagulated animals and in ex vivo vessels in which saline has been substituted for blood. Overview of the Present Invention
FIGURES 1 and 2 show the main components of an ultrasonic system suitable for use in implementing the present invention. As illustrated in FIGURE 1 , a hand-held applicator unit 2 is positioned over an arterial wound 8 in the patient. Included with the hand-held applicator unit is a generally single-use, pre-sterilized cover and acoustic coupling shell 4 that slips over applicator 2. A control unit 6 implements algorithms to facilitate the method and is coupled to applicator 2.
The user enters various conventional scan and control parameters into an input unit 70, which typically includes user input devices 72. Examples of such devices include a keyboard, knobs, and buttons. The input unit is connected to a processing system 74, which will typically comprise a plurality of microprocessors and/or digital signal processors. Processing system 74 may, however, also be implemented using a single processor of sufficient speed to handle the various tasks described below. A conventional memory 75 will normally be included in the system to store, among other data, transmission control parameters and imaging data generated in any given implementation of the present invention.
Processing system 74 sets, adjusts, and monitors the operating parameters of a conventional transmission and control circuit 76. Control circuit 76 forms a transmit ultrasonic waveform by generating and applying electrical control and driving signals to an ultrasound transducer 78, which preferably comprises an array of individually controllable piezoelectric elements. As is well known in the art, the piezoelectric elements generate ultrasonic waves when electrical signals of a proper frequency are applied to them; conversely, when receiving reflected ultrasonic waves, they generate electrical signals corresponding to the mechanical vibrations caused by the returning ultrasonic waves.
Transducer 78 is positioned against a portion 82 of the body of a patient, and by varying the phasing, amplitude, and timing of the driving signals for the transducer anay elements, ultrasonic waves are focused to form a transmit beam 314 of high-intensity ultrasound.
In FIGURE 2, open anows indicate the direction of a flow of blood within a blood vessel 312, which has a puncture site 316 that may have been caused by introduction of a catheter or, in the case of unintended punctures that have produced wounds, by some other object. The tissue forming a layer 318 of collagen found on the surface of blood vessels is also shown in FIGURE 2 sunounding blood vessel 312. As will be clear from the description of the present invention below, it is not necessary for the system to include an imaging capability. However, the provision of an imaging capability, including pulse-echo lines of interrogation that are not displayed as images, in the present invention should assist a user to more accurately locate a vascular puncture site. It is recognized that a full display of the insonified vascular target site is not required.
Nonetheless, since imaging of a vascular target site is preferable and will employ echo processing (especially, Doppler), FIGURE 2 also illustrates a reception controller 78, which will include conventional amplification and signal conditioning circuitry as needed. Reception controller 88, all or part of which is normally integrated into processing system 74, converts the ultrasonic echo signals (which are typically at radio frequencies, on the order of a few to tens of megahertz) into lower frequency ranges for processing and may also include analog-to-digital conversion circuitry. The processing includes, as needed, such known signal conditioning as time-gating, gain compensation, Doppler frequency shift processing, and diffraction compensation, in order to identify echo signals from any selected focal region. The type of conventional signal processing needed (if any) will in general depend on the particular implementation of the present invention employed and can be implemented using known design methods.
Note that it is not essential, according to the present invention, that the transducer 78 be used externally, relative to the patient's body. It is also contemplated that the transducer may be maneuvered inside a patient's body, and the beam focused on a puncture from inside the body. For example, a transesophageal probe, laparoscopic, or other probe inserted into a body cavity, such as the vagina or rectum can be used to practice the present invention. A suitably designed probe inserted into an open body cavity or via minimally invasive means could be used to arrest bleeding in surgical or trauma care situations. Yet, most of the following discussion is directed to a preferred embodiment of the present invention in which the transducer is intended to be used externally, since an initial commercial product in accord with the present invention will be designed for such use.
A conventional display system 92 may also be included in order to display information concerning transmission power, time, focus data, etc. The display system will include known circuitry for scan conversion and for driving the display, as needed. These circuits are well known and therefore need not be specifically illustrated or described further to provide an enabling disclosure. FIGURE 3 illustrates the result of an insonification of puncture site 316 using the present invention. As the focal point of transmit beam 314 (see
FIGURE 2) is moved around (as illustrated by the arrows pointing in either direction from the focus of the beam) the area of puncture site 316 using conventional beam-steering techniques, the tissue adjacent the puncture site 316 will denature. In effect, the collagen in the tissue "melts" and flows over and into the puncture opening. When the collagen cools, it forms a "patch" that not only covers the puncture, but also flows partially into the puncture opening in the wall of the blood vessel. Moreover, since the denatured tissue tends to contract, it also tends to pull the edges of the puncture together and thus further close the wound.
It should be noted that the present invention can be employed to seal vascular wounds of various types and is not limited to the type of wound created as a result of interventional procedures in which a catheter has been introduced into a vascular vessel. As noted above, application of thermal treatment to the tissue overlying a wound has been demonstrated to seal the wound. In the present invention, a practical method has been developed for repeatedly and reliably achieving sealing of the puncture in a vascular vessel. Steps carried out in this method are shown in FIGURE 4, which is discussed below. These steps represent one prefened embodiment of the present invention, but do not represent all alternatives that might be employed to achieve acceptable sealing.
Key steps in the method for vascular sealing described here include: 1. Positioning an ultrasound generating source on a patient such that the source is targeted at an area including the wound to be sealed; 2. Applying a pressure against the patient in an area overlying the wound and directed substantially toward the vessel to be treated;
3. While the pressure and the positioning of the ultrasound source are maintained, canying out an insonification of a volume of tissue that includes the wound, using an ultrasound exposure that delivers an acoustic energy density (measured at the approximate location of the wound), in excess of lOOjoules/sq. cm, but generally less than several thousand joules/sq. cm. Additional steps of the method described below employ the apparatus in an automated manner that facilitates ease of use and ensures the safety and consistency of the results obtained. A clinically acceptable device for sealing a puncture wound in accord with the present invention must meet a number of requirements, including:
1. The device and associated procedure must be safe to use in that they avoid undesirable bioeffects, so that the patient is not injured directly or indirectly as a result of the procedure; also, in the event that effective vessel sealing does not occur as desired, traditional methods of applying pressure to the wound are sufficient to accomplish hemostasis;
2. The device and associated procedure must be easy to use in an efficient manner, to facilitate proper, repeatable execution of the sealing process; requirements for operator training should be minimized;
3. The sealing process must be sufficiently fast to enable the entire procedure to be rapidly completed - preferably, in less than 5 minutes;
4. The cost per sealing procedure should be minimized; and,
5. The efficacy of the device should be very high, generally achieving a success rate in excess of about 95%; acceptability of the present invention in routine clinical practice does not permit an unpredictable outcome.
These requirements are met by the present invention, as described below, and as defined in the claims that follow. A preferred embodiment of the device includes the components shown in FIGURES 1 and 2, which were described above.
FIGURE 6 and FIGURE 6A show one prefened embodiment of applicator unit 2. The applicator unit includes an outer housing 10 having an ergonomically considered shape so that it can be conveniently hand held. The outer housing is best fabricated from an injection moldable plastic material such as ABS or the like. The operator grasps the outer housing of the applicator unit so as to enable a control push- button 14 to be accessible and indicators 12, 16 and 30, 32, 34, and 36 to be visible to the operator. Positioning the applicator unit at the appropriate location over the wound area and activation of an essentially automated treatment cycle are readily accomplished. The operator simply refers to the indicators to determine when the applicator unit is properly positioned and ready for use. Indicators 12 and 16 are used to indicate when alignment of the applicator unit with the longitudinal axis of the vessel to be sealed has been achieved. Indicators 30, 32, 34, and 36 display the state of operation and instruct the operator with respect to holding the applicator in place as described in detail later in this description. Control 14 when pressed, activates the treatment cycle, thus initiating a sequence of operations that determine ultrasonic scan parameters (exposure time, scan pattern, intensity, focal range, etc.).
As shown in FIGURE 6A, ultrasonic array assembly 20 is held within outer housing 10 on a shaft 40, in a bearing assembly within a force transducer 18, so as to permit movement of the ultrasonic array assembly to and away from patient 8. Shaft 40 passes through the bearing assembly provided within a force generator 18 and terminates at a contacting force sensing transducer 42. Force generator 18 comprises an electromagnetic solenoid that is rigidly supported and mounted within housing 10 by structural members 46. The face of ultrasonic array assembly 20 is in contact with the appropriate location on the body of the patient (overlying the site of the puncture) and is thus capable of applying a substantially compressive, controllable force on the tissue structures with which it is in contact. The force applied by the ultrasonic array assembly is produced at least in part by controllably energizing force generator 18. Ultrasonic array assembly 20 preferably operates in a multiplicity of modes; however, separate ultrasonic transducers can instead be provided for some or all of the functions performed in a different design within the scope of the present invention.
In the illustrated preferred embodiment, electrical connections comprising wires 26 are routed within the outer housing 10 and out in a sealed bushing 44 that mounts a cable 28 to the control unit 6. Cable 28 is sufficiently long, on the order of 10 feet in length, so that the control unit may be conveniently located at a distance from the patient and operator location.
Applicator unit housing 10 is shaped to be used with a slip-on, generally single-use protective applicator shell 4 (illustrated schematically in FIGURE 1). The shell employed in the preferred embodiment is shown in greater detail in FIGURES 8 and 8A. Shell 4 has side walls 54 that are fabricated from a generally optically transparent, semi-rigid plastic material. A skirt 52 extends from the rear of the shell and is pleated so that in preparing for use of the applicator unit, an operator can grasp the skirt and extend it sufficiently to protect a sterile area of the patient from coming into contact with cord. The protective shell is packaged in a sterile condition. The shell is fabricated from a flexible plastic material having low acoustic absoφtion characteristics. A fiducial mark 56 is provided on a side of the applicator unit and visible through the optically transparent material of the protective shell. This fiducial mark is employed to visually align the applicator unit with a position on the patient at which the applicator unit will be used to seal a puncture.
Sterile, generally gas free acoustic coupling gel 62 is deposited in a patch on the bottom of flexible bottom 58. Prior to use, the gel is held in place and sealed by semi-sticky adhesive coated tab 60. Tab 60 is removed by the operator just prior to use, thereby exposing the gel so that it provides a good acoustic coupling with the surface of the patient's body. Protective applicator shell 4 thus provides a sterile barrier over the multi-use applicator unit and conveniently provides a pre-determined amount of a specific appropriate acoustic coupling medium. Although not shown, it is contemplated that the bottom of the interior cavity of the shell may also include a layer of acoustic coupling gel to ensure good acoustic coupling between the applicator unit through the protective, applicator coupling shell.
With reference to FIGURE 1 , applicator unit 2 is connected to control unit 6. Power supplies, signal processing components, and control and RF power generation components are housed within control unit 6. FIGURE 9 is a system block diagram illustrating the modules disposed, in the preferred embodiment, within the applicator unit 2 (i.e., the component shown within the dotted line portion of this Figure) as well as the modules (all other modules that are not in the applicator unit) disposed in the control unit 6. In this preferred embodiment, control unit 6 is packaged in a small, self-contained pole- or cart-mounted enclosure that derives its input power from a standard AC line power service (not shown). Power supplies with the unit are designed to assure low leakage currents for patient safe operation. In the preferred embodiment the architecture of control unit 6 is based on a programmable processing unit which processes various signals and controls a number of functional modules. A microprocessor is well suited to perform the computation and control functions required. Applicator unit 2 is coupled to control unit 6 by a plurality of signal paths 212, 214, 216, and 218. Signal path 212 couples display drivers 200, which are controlled by a computer/controller 236, with indicators 30, 32, 34, and 36 on the applicator unit. Control button 14 on the applicator unit is coupled through signal line 214 to an interface 202 and thus to the computer/controller. Force sensing transducer 42 produces an output signal indicative of the force (i.e., the pressure) applied against the surface of the patient's tissues by the applicator unit, and this signal is conveyed by signal lines 216 to an interface 204, which provides the signal to the computer/controller. In response to the magnitude of the monitored force, the computer/controller produces a control signal applied to a driver 206, which provides the current signal used to energize force transducer 16, to determine any additional force that it generates to achieve a desired pressure on the site of the puncture that is sufficient to prevent loss of fluid from the vessel, but not so great as to occlude the flow of fluid through the vessel.
Signal lines 240 couple ultrasonic anay assembly 20 to a transmit/receive switch 224. The transmit/receive switch determines the operational mode of the ultrasonic anay assembly under the control of the computer/controller. When operating in a diagnostic mode in which the ultrasonic anay assembly is producing an imaging ultrasound beam, the signal corresponding to the echo reflected received by ultrasonic array assembly 20 from tissue and other structures is conveyed through transmit/receive switch 224 and through signal lines 222 to an amplifier digitizer anay 220. The output signals from the amplifier digitizer array are conveyed to computer/controller 236 through signal lines 228. When the ultrasonic array assembly is generating either the imaging beam or the HIFU beam, it is responding to signals received from an RF generator 232 that is coupled to a phase shift/amplifier array 234 by signal lines 236, and to a control signal provided by the computer/controller and conveyed to the phase shift/amplifier on a signal line 230. The output of the phase shift/amplifier is conveyed on signal lines 226 to transmit/receive switch 224, and thus, to ultrasonic array assembly 20 through signal lines 240. Manual control inputs 241 are coupled to computer/controller 236 through signal lines 242.
A number of variously advantageous transducer configurations may alternatively be employed in this invention. Possibilities include: • Configurations wherein therapeutic and, pulse-echo Doppler functionality are accomplished by the same ultrasonic transducer or by separate ultrasonic transducers; and,
• Configurations wherein the ultrasonic transducer is either of a fixed focus type, or a segmented electrically selectable macro element array, or a phased array, or a linear array, or an annular anay; and,
• Configurations where a large focal spot 412 (see FIGURE 13) (e.g. a focal spot produced by a transducer having an aspheric shape), or those in which a tightly focused spot is produced; and,
• Configurations wherein the ultrasonic transducer is mechanically positioned (or scanned), or those in which it is fixed in one position.
An aspheric ultrasonic transducer configuration has the advantage of covering a large treatment area on the surface of the vessel without the complication of electronic or mechanical beam steering. Covering a large area (i.e., overscanning) is desired in order to ensure that the actual site of the puncture wound is treated, given its positional ambiguity. FIGURE 13 depicts the geometry of such a configuration. In this embodiment, an ultrasonic transducer 404, excited by an appropriate RF source via connections 402, is generally aspheric in shape and does not bring the ultrasound beam to a shaφ focus. The ultrasonic energy that it produces covers area 412 on a vessel 408 that includes puncture wound 410. Fluid or solid material acoustic coupling (not shown) is used between the ultrasonic transducer and the tissues of the patient. In one preferred embodiment, the method described includes a series of manual steps (operator actions) and automated steps. The automated steps are carried out as control processes or algorithms executed by one or more processors and other hardware in accord with machine instructions executed by the one or more processors. It is understood that variations in the order of these steps, and in the total complement of steps implemented is possible in alternative embodiments. Steps as shown in FIGURE 4 are described as follows.
In a step 100 labeled Patient Preparation, the operator positions the patient and the apparatus so that the applicator unit is conveniently positioned over the puncture wound area, e.g., over the puncture made by a catheter in the femoral artery. Shell 4 is removed from its sterile package and fitted onto applicator unit 2, and gel sealing tab 60 (shown in FIGURES 8 and 8A) is removed, exposing the gel 62.
A step 102 labeled Manually Align is then carried out. With the catheter introducer in the wound, the operator palpates the area locating the point at which the introducer just enters the artery. The operator marks this location on the patient's skin with a suitable marking device (e.g. a surgical marker), drawing a line substantially peφendicular to the perceived direction of the artery, extending approximately 3 cm from the entry wound location. It is the puφose of this marking to estimate the longitudinal location of the wound; the operation of the HIFU sealing process provides for an overscan of the wound area so that practical variations in the operator's ability to make the longitudinal position estimate are permissible. Other techniques for locating the site of the puncture are discussed below. In a more preferred embodiment, lateral and range locations of the wound are more precisely located by the automated capability of the processor(s) used in the apparatus.
Also within step 102, the operator places the device over the wound location, aligning fiducial mark "56" (shown in FIGURE 8) with the line that was drawn on the patient's skin. The applicator unit is rotated in place until both alignment indicators 12 and 16 (FIGURES 6 and 8) illuminate, indicating that the artery is axially aligned under the applicator unit.
The axial alignment indications are, in this preferred embodiment, derived from two ultrasonic pulsed Doppler interrogations. FIGURES 10 and 10A show the geometry of the Doppler alignment beams. Use of a ultrasonic transducer 20 enables the same ultrasonic transducer to be employed to produce an imaging beam and the HIFU beam for both a pulse-echo targeting mode and a therapeutic mode. In the alignment sequence illustrated in FIGURES 10 and 10A, phased array ultrasonic transducer 20 sends and receives a downstream pulsed Doppler line 304 and an upstream line 308 sequentially. Lines 304 and 308 are in plane with the axial centerline of the applicator unit and a line peφendicular to the bottom surface of the applicator unit. Lines 304 and 308 are transmitted at angles A and B with respect to a line 306, which is peφendicular to the applicator unit. Angles A and B are chosen to provide a axial separation as well as an appreciable vector flow component in the direction of the interrogating line - an angle of approximately 45 degrees. Direction of flow in an interior 310 of the vessel is sensed and tested to assure that an artery 300 (not a vein) is being interrogated. Doppler signals, from lines 304 and 308, integrated over an appropriate range, above a pre-determined threshold value, are used to cause the illumination of alignment indicators 12 and 16 respectively. Averaging multiple lines is, in this prefened embodiment, employed to improve the performance of the alignment detection scheme. The conditioned signals also set logical flags so that the system may interlock the initiation of a therapeutic treatment sequence with assurance of alignment. Thus in a decision step 106 (FIGURE 4), alignment is tested by interrogating the logical presence of both of the flags.
Alternatively, another advantageous configuration for guiding the manual alignment process uses multiple Doppler lines and multiple indicators, with reference to FIGURE 1 1 , which illustrates a top view of the applicator unit. In this configuration, three parallel lines are transmitted and received in the two directions indicated by lines 304 and 308 in FIGURE 10. Additional transducers are appropriately positioned in housing 10 (FIGURE 6). Pulsed Doppler signals are processed in a manner similar to that described above. Thus, for example (refening to FIGURE 11), if the alignment is off-center and rotated to the left, indicator lights 336 and 334 would be illuminated, indicating the misalignment and suggesting the appropriate direction to move the applicator unit to achieve align ent (denoted when indicators 338 and 330 are illuminated). Alternatively, continuous wave Doppler may be employed to interrogate the flow position of the target artery, with operation essentially similar to that described above.
With verified alignment in step 106, the system proceeds to a step 108 labeled Set Pressure, wherein the pressure over the artery is set and controlled within a predetermined range using force generator 18 (FIGURE 6) and force sensing transducer 42. In this preferred embodiment, the weight of the applicator unit is puφosefully made to be in a range where additional pressure applied by the operator to hold the unit firmly in place is reduced. This useful weight is about 1 lb (0.45 kg) or more. Force generator 18 is activated and controlled such that applied pressure to the artery partially restricts flow, but maintains sufficient flow so that thermal cooling due to blood flow within the artery protects the intimal lining of the vessel from irreversible damage. Presence of a Doppler flow signal on down-stream line 304 (FIGURE 10) is employed to assure vessel patency. In this preferred embodiment, when the system has completed the pressure application cycle described above, indicator 32 (FIGURE 6), which is marked "READY" on the applicator unit is illuminated (see block 1 18 FIGURE 4), indicating to the operator that a treatment cycle may be manually initiated (triggered) by pushing control button 14. The system is in a wait state as indicated in a decision block 1 12 in FIGURE 4, until a manually triggered treatment cycle is detected. With the detection of a triggered treatment cycle, axial alignment is verified in a step 1 14 by generally repeating the logical test described at step 102.
A step 1 16 then makes a ranging measurement to estimate the acoustic path length between ultrasonic transducer assembly 20 and the vessel boundary, i.e., the distance between points F and C along line 306 in FIGURE 10. Pulsed Doppler is, in this preferred embodiment, employed to make this measurement, wherein lines 304 and 308 measure distances F-D and F-E, respectively. Points D and E are recognized by the fact that these correspond to the first instance of flow detected along each line as range increases. The range estimate of FC is therefore:
FC ~ (FE COS A + FD COS B)/2 Equation 1
A step 120 estimates the acoustic attenuation at the therapeutic frequency between ultrasonic transducer assembly 20 and the target collagen layer overlaying the vascular wound, path F-C in FIGURE 10. In this preferred embodiment, a simplified approach is employed wherein estimated dimension FC is used to access data in a look-up table of attenuation values. Attenuation values in the table are predetermined by empirical measurement. Alternatively, more sophisticated A-Mode attenuation measurements may be employed to assess to F-C path.
A step 122 determines the therapeutic ultrasound exposure parameters to be employed. Dimension F-C, the attenuation estimate, and optionally, patient parameters (e.g., size and weight), input at module 240 in FIGURE 9, are used to access predetermined data and scan protocols in resident look-up tables Ultrasound scan geometry, intensity and epochal exposure intervals are thus determined. Ultrasound scan geometry, intensity and time parameters are determined to accomplish three key objectives: (1 ) provide a sufficient overscan of a longitudinal and lateral surface of the target vessel so as to include the site of the wound; (2) ensure delivery of an appropriate energy dose to the collagen layer in the region of the target site to raise its temperature to a range of between 60 and 100 degrees Celsius for a predetermined period of time; and, (3) assure that the skin and inteφath tissue is not exposed to a temperature-time exposure that will result in pain and or irreversible tissue damage.
Therapeutic scan geometry is shown in FIGURES 12A and 12B. A therapeutic level of approximately 50 watts total transmitted acoustic power, generally weakly focused, is transmitted along a centerline 314 through a dermal layer 302. The desired scan pattern is achieved by directing the beam over varying angles of the beam with respect to a line 320 that extends peφendicular to the center of the face of the application unit. Thus, for example, a raster scan pattern may cover a therapeutic area, over collagen layer 318, of dimensions 1 cm wide by 1.5 cm long ( in the arterial axial direction). Such an overscan of the wound site provides for variations in the operator's ability to predetermine and locate the precise lateral position of the wound, as well as the variation in wound location that results from the possible variation of wound lateral entry points. Importantly, scan geometry is selected such that ultrasonic exposure is generally confined to the vessel, minimizing the possibility that an adjacent vein or nerve structure will be insonified.
A step 126 carries out the therapeutic exposure cycle. It is generally desirable to hold the applicator unit in place, providing the established orientation and pressure for a period of time after the therapeutic exposure cycle. A hold interval 130 (FIGURE 4) is selected to enable exposed tissue structures to cool, a time period of approximately 1 minute. Following this time period, indicator 36 on the application unit (FIGURE 6) marked "COMPLETE" is illuminated and the "HOLD" indicator is turned off, instructing the operator that the therapeutic treatment is completed and the device may be removed from the patient.
In situations where there is concern for inadvertent exposure of a nerve structure, an additional sequence depicted in FIGURE 4A may optionally be employed. The sequence is inserted into the process flow of FIGURE 4, in this prefened embodiment, at a location marked "A." To detect the presence of a nerve structure, a weak, sub-therapeutic energy level ultrasonic pulse is transmitted in a step 136 (FIGURE 4A), to cover the determined target area. The operator observes in a decision step 138 whether a reaction of pain and or uncommanded movement from the patient has occurred, indicating that a nerve structure has been stimulated. System logic then waits for an addition manually initiated trigger input in steps 140 and 142, prior to proceeding with therapeutic exposure at step 126 in FIGURE 4. Alternative Techniques for Aligning the Applicator unit Step 102, which facilitates alignment of the applicator unit over the wound area and targeting of the therapeutic exposure, may be accomplished using several alternative approaches compared to that described above. It is desired to employ an approach for targeting and aligning the applicator unit that is easy to implement and requires minimum operator instruction. The approach further should be consistent with minimizing bleeding during the process of achieving alignment. Additionally, the approach should be robust and provide targeting of the wound site with sufficient accuracy such that the wound will reliably be included within the area of therapeutic exposure.
A principle employed in the present invention is the concept that the overscan of the target location during therapeutic exposure is sufficient to accommodate targeting ambiguity and possible patient or operator movement during the procedure. Nevertheless, accurate targeting is needed to ensure efficacy of the wound sealing process.
In the prefened embodiment described above, pulsed Doppler ranging was employed to locate the axis of the vessel, and the operator was advised of the longitudinal location of the wound on the vessel by reference to visual landmarks on the skin surface. Alternatively, by inclusion of additional automation, the need for the operator to locate the longitudinal position is eliminated, thereby substantially simplifying the targeting procedure for the operator. These alternative approaches make use of the entry channel along which the introducer and guide wire are commonly passed during diagnostic and interventional catheterization procedures. FIGURE 5 illustrates the geometry that relates the location of applicator unit 2 to the locations of an entry channel 518 and a vessel wound 516. In FIGURE 5, applicator unit 2 is positioned on a patient's skin surface 510 over a vessel 506 in which a blood flow 508 is contained. A location "C" is indicated at wound 516; a line 512 passes from "C" through entry channel 518, intersecting a plane 514 defined by reference locations on applicator unit 2 at a point "H." A point "F" is a reference point in plane 514. If the spatial location of line 512 is known relative to plane 514 and point "F," and the vector distances "H" to "F", or "C" to "F" are known, then the location of wound 516 relative to applicator unit 2 is determinable by basic geometry. Knowledge of this geometry permits automated system function to be employed to provide guidance instructions (e.g. visual indicators) to the operator during the manual alignment portion of the procedure.
A sufficient number of the parameters in the above described geometry may be determined by several novel methods and their associated apparatus. As previously described, acoustic pulsed Doppler may be employed to determine the distance "C" - "F" (reference FIGURE 5). In many applications of the vascular sealing method described herein, the vessel is an artery having a substantial high velocity flow and is thus readily localized using well known pulsed Doppler techniques. Knowing this distance, localization of wound 516 on the vessel is made possible by determining the spatial position of line 512.
The spatial location of line 512 may be determined by employing a substantially rigid, straight locator rod 554 as depicted in FIGURE 7, which is placed in entry channel 518. Locator rod may have a longitudinal center bore 556 through which a guide wire 552 may pass. In practical use, the introducer used in conjunction with a clinical procedure would be removed without removing the guide wire. Locator rod 554 would be introduced into the wound over the guide wire. Sealing assembly 550 is disposed at one end of the locator rod to prevent the loss of blood through center bore 556.
Several alternative approaches may be employed to determine the spatial location of the longitudinal axis of locator rod 554 and thus, to determine precise wound location as described above. These approaches include:
1. As shown in FIGURE 7A, a spatial position resolving element 558 may be included on locator rod 554. Spatial position resolving element 558 may be an acoustic position sensor, an optical position sensor, a magnetic position sensor, an electromechanical positioning or resolving arm, or an inertial position sensor. The spatial relationship between the position of al¬
locator rod 554 and applicator unit 2 is accomplished by either a direct mechanical linkage or by way of an intermediate electronic or computational circuit.
2. As shown in FIGURE 7B, an ultrasonic pulse-echo technique may be employed to determine the spatial location of locator rod 554. A transducer in applicator unit 2 transmits directed acoustic pulses in more than one direction, e.g., lines 560, 562, and 564, and echoes from structures in each path are returned and detected by a pulse-echo receiver included in the applicator unit, as is well know in the diagnostic ultrasound art. Locator rod 554 provides reflections that permit making time of flight measurements of, for example, distances "F"-"I," "F"-"K," and "F"-"L." Locator rod 554 may be coated or constructed of materials chosen to enhance acoustic reflectivity, thus providing echoes that are readily distinguished from background clutter.
Common guide wires may alternatively be used as locator rod 554, as these wire structures are typically highly reflective of ultrasound energy. Alternatively, locator rod 554 may be constructed from materials that enhance reflection at a harmonic of the interrogating ultrasound pulse, providing another advantageous method for clearly distinguishing the echoes from locator rod 554 from those received from surrounding tissue. Materials or coatings that entrap gas bubbles are, for example, effective in providing higher harmonic reflection. Echo enhancing properties may also be incoφorated into an introducer that is then used as the locator rod.
Pulsed Doppler may also be employed to identify and locate the locator rod. In this latter alternative, the locator rod may be a common introducer. A strong Doppler shifted reflection will return from the lumen of the introducer even when blood is not permitted to flow out of the introducer.
3. As indicated in FIGURE 7C, two dimensional, or three dimensional, imaging may also be employed to locate locator rod 554, the guide wire, and the introducer, as well as the vessel. FIGURE 7C depicts a view of a framed two-dimensional image 580 of the target region generally orthogonal to that shown in FIGURES 7 A and 7B. Distance from the ultrasound source increases toward the bottom of this depiction. This image is generally representative of a cross-sectional plane of interrogation located at a line 562 in FIGURE 7B. Automated image recognition provided by the processor may be employed to identify structures including locator rod 554, imaged as a locator rod structure 586 and vessel 506, imaged as a vessel structure 584 in this image.
Doppler imaging and color flow mapping may be employed to increase the recognizablility of relevant features. The interrogating image plane may be scanned over the region containing the target. When locator rod structure 586 is recognized at a location just touching the top surface of vessel structure 584, the wound target site has been identified. Although the present invention has been described in connection with the preferred form of practicing it, those of ordinary skill in the art will understand that many modifications can be made thereto within the scope of the claims that follow. Accordingly, it is not intended that the scope of the invention in any way be limited by the above description, but instead be determined entirely by reference to the claims that follow.

Claims

The invention in which an exclusive right is claimed is defined by the following:
1. A method for closing a puncture in a vascular vessel of a patient, comprising the steps of:
(a) determining a site of the puncture in the vascular vessel;
(b) positioning an ultrasonic transducer applicator at a position adjacent to the site that was determined;
(c) coupling the ultrasonic transducer applicator to a control that includes a processor programmed to control administration of ultrasonic energy to efficaciously seal a puncture; and
(d) enabling a user to initiate a process that is controlled by the control, said control automatically controlling the ultrasonic transducer applicator so that the ultrasonic energy produced by the ultrasonic transducer applicator is focused at the site and is administered to the site at a sufficient intensity and duration to denature tissue at the puncture, closing and sealing the puncture.
2. The method of Claim 1 , wherein the step of determining the site of the puncture comprises the steps of:
(a) generating an imaging ultrasonic beam with the ultrasonic transducer applicator, said imaging ultrasonic beam being transmitted into the patient proximate an expected location for the site;
(b) receiving a reflection of the imaging ultrasonic beam from within the patient with the ultrasonic transducer applicator, producing a corresponding output signal; and
(c) processing the output signal with the processor in the control, to determine the site of the puncture.
3. The method of Claim 2, further comprising the step of providing a visual indication of a location of the site of the puncture, thereby enabling an operator to position the ultrasonic transducer applicator so that the ultrasonic energy produced by the ultrasonic transducer applicator is directed at the site of the puncture.
4. The method of Claim 3, wherein the visual indication comprises an image of the site in which an axis of the vascular vessel is visually evident, and wherein the step of enabling the operator further comprises the step of positioning the ultrasonic transducer applicator longitudinally along the axis of the vascular vessel so that the ultrasonic energy produced by the ultrasonic transducer applicator is directed at the site of the puncture.
5. The method of Claim 4, further comprising the step of providing an object that extends from outside the patient into the puncture.
6. The method of Claim 5, wherein the step of positioning includes the step of estimating the location of the puncture along the longitudinal axis of the vessel based upon a disposition of the object extending outside the patient.
7. The method of Claim 5, wherein the visual indication comprises an image of the site in which the object extending into the puncture is evident, further comprising the step of estimating the location of the puncture based upon a disposition of the object in the image.
8. The method of Claim 3, further comprising the steps of:
(a) processing the output signal with the processor to determine the site of the puncture;
(b) controlling an indicator disposed on the ultrasonic transducer applicator to provide an indication of a direction in which the ultrasonic transducer applicator should be moved to be adjacent to the site of the puncture.
9. The method of Claim 3, further comprising the step of using the processor for automatically controlling at least one of a direction, the intensity, and a focus of the ultrasonic energy, to ensure that the ultrasonic energy is administered to the site of the puncture.
10. The method of Claim 9, wherein the processor directs the ultrasonic energy so as to overscan the site of the puncture, ensure that the puncture is closed and sealed.
1 1. The method of Claim 10, wherein the processor moves the focus of the ultrasonic energy while administering the ultrasonic energy, to overscan the site of the puncture.
12. The method of Claim 1, wherein an ultrasound emitter of the ultrasonic transducer applicator has an aspheric shape so that the ultrasonic energy that is directed at the site of the puncture overscans the site, thereby ensuring the ultrasonic energy is applied to the site of the puncture.
13. The method of Claim 2, wherein the ultrasonic transducer applicator uses a common anay of transducers for generating both the imaging ultrasound beam and the ultrasound energy that closes and seals the puncture.
14. The method of Claim 2, further comprising the step of interrupting the administration of the ultrasonic energy to again generate the imaging ultrasound beam, thereby confirming whether the ultrasonic energy is being directed at the site of the puncture.
15. The method of Claim 1, further comprising the step of employing the processor to control a force applied against a surface of the patient with a force generator included in the ultrasonic transducer applicator, said force being controlled so that a pressure developed by said force is sufficient to substantially stop fluid leakage from the vascular vessel, but not so great as to substantially occlude fluid flow through the vascular vessel.
16. The method of Claim 1 , further comprising the step of enclosing a ultrasonic transducer within a protective shell to provide the ultrasonic transducer applicator, said protective shell being adapted to contact an external dermal portion of the patient in order to convey the ultrasonic energy transdermally to the site of the puncture and protecting against a direct contact between the ultrasonic transducer and the external dermal portion of the patient.
17. A method for closing a puncture in a vascular vessel of a patient, comprising the steps of:
(a) determining a site of the puncture in the vascular vessel;
(b) providing a protective applicator shell for an ultrasonic transducer;
(c) mating the ultrasonic transducer with the protective applicator shell to provide an ultrasonic transducer applicator;
(d) positioning the ultrasonic transducer applicator externally on the patient, adjacent to the site determined for the puncture in the vascular vessel;
(e) energizing the ultrasonic transducer applicator to administer ultrasonic energy to the puncture in the vascular system, said ultrasonic energy denaturing tissue at the puncture, closing and sealing the puncture.
18. The method of Claim 17, further comprising the step of removing a cover overlying a gel disposed on a face of the protective applicator shell prior to the step of positioning the ultrasonic transducer, said gel providing an ultrasonic coupling interface between the ultrasonic transducer and a dermal surface of the patient through which the ultrasonic energy is conveyed.
19. The method of Claim 17, wherein the step of determining the site of the puncture comprises the steps of:
(a) generating an imaging ultrasonic beam with the ultrasonic transducer applicator, said imaging ultrasonic beam being transmitted into the patient proximate an expected location for the site;
(b) receiving a reflection of the imaging ultrasonic beam from within the patient with the ultrasonic transducer applicator, producing a corresponding output signal; and
(c) using the output signal to determine the site of the puncture.
20. The method of Claim 19, further comprising the step of providing a visual indication of a location of the site of the puncture, thereby enabling an operator to position the ultrasonic transducer applicator so that the ultrasonic energy produced by the ultrasonic transducer applicator is directed at the site of the puncture.
21. The method of Claim 20, wherein the visual indication comprises an image of the site in which an axis of the vascular vessel is visually evident, and wherein the step of enabling the operator further comprises the step of positioning the ultrasonic transducer applicator longitudinally along the axis of the vascular vessel so that the ultrasonic energy produced by the ultrasonic transducer applicator is directed at the site of the puncture.
22. The method of Claim 21 , further comprising the step of providing an object that extends from outside the patient into the puncture.
23. The method of Claim 22, wherein the step of positioning includes the step of estimating the location of the puncture along the longitudinal axis of the vessel based upon a disposition of the object extending outside the patient.
24. The method of Claim 22, wherein the visual indication comprises an image of the site in which the object extending into the puncture is evident, further comprising the step of estimating the location of the puncture based upon a disposition of the object in the image.
25. The method of Claim 17, further comprising the step of overscanning the site of the puncture with the ultrasonic energy to ensure that the ultrasonic energy is administered to the seal the puncture.
26. The method of Claim 19, wherein the ultrasonic transducer applicator uses a common array of transducers for generating both the imaging ultrasound beam and the ultrasound energy that closes and seals the puncture.
27. The method of Claim 19, further comprising the step of interrupting the administration of the ultrasonic energy when sealing the puncture to again generate the imaging ultrasound beam, thereby confirming whether the ultrasonic energy is being directed at the site of the puncture.
28. The method of Claim 17, further comprising the step of activating a force generator included within the ultrasonic transducer applicator to produce a pressure applied against a dermal layer of the patient over the site of the puncture.
29. The method of Claim 28, further comprising the step of providing an indication that the pressure being applied to the site of the puncture is sufficient to substantially prevent a fluid from leaking from the vascular vessel, but not so great as to substantially occlude a fluid flow through the vascular vessel.
30. Apparatus adapted to seal a puncture in a vascular vessel of a patient, comprising:
(a) an ultrasonic transducer applicator that controllably radiates ultrasonic energy and which is adapted to:
(i) couple the ultrasonic energy into a body of a patient;
(ii) controllably focus the ultrasonic energy on a puncture disposed in a vascular vessel of a patient; and
(iii) administer the ultrasonic energy to the site at an intensity sufficient to denature tissue, closing and sealing the puncture; and
(b) a controller that is coupled to the ultrasonic transducer applicator, said controller including a processor and a memory in which are stored machine instructions, said machine instructions, when executed by the processor, causing it to control a plurality of parameters affecting administration of the ultrasonic energy to the site by the ultrasonic transducer applicator, said parameters being controlled by the processor so as to efficaciously close and seal a puncture in a vascular system of a patient.
31. The apparatus of Claim 30, further comprising a display coupled to the controller, said ultrasonic transducer applicator being controlled by the controller to produce an imaging ultrasonic beam adapted to be transmitted into a patient proximate an expected location for the site of the puncture, said ultrasonic transducer applicator producing an output signal in response to receiving a reflection of the imaging ultrasonic beam, said output signal being used to provide an image on the display useful for determining the site of a puncture.
32. The apparatus of Claim 31 , further comprising an object that is adapted to be introduced into a puncture and to extend externally, said object providing a visual indication of a location of a site of a puncture.
33. The apparatus of Claim 32, wherein the object is at least in part formed of a material that is clearly visually evident on the display, to assist in determining a site of a puncture.
34. The apparatus of Claim 33, wherein a portion of the object adapted to be disposed at a puncture comprises a material that is more visually evident on the display than other portions of the object, to assist in determining a site of a puncture.
35. The apparatus of Claim 30, wherein the ultrasonic transducer applicator includes an indicator that is coupled to the controller, said controller responding to the output signal to provide a visual indication with the indicator, said visual indication denoting a direction in which the ultrasonic transducer applicator should be moved to enable the ultrasonic energy to be more accurately directed at a puncture site.
36. The apparatus of Claim 30, wherein the processor automatically controls at least one of a direction, an intensity, and a focus of the ultrasonic energy, to ensure that the ultrasonic energy is administered to a site of a puncture.
37. The apparatus of Claim 36, wherein the machine instructions executed by the processor control the ultrasonic transducer applicator to direct the ultrasonic energy so as to overscan a site of a puncture, to ensure that a puncture is closed and sealed thereby.
38. The apparatus of Claim 36, wherein the machine instructions executed by the processor control the ultrasonic transducer applicator to shift a focus of the ultrasonic energy to overscan a site of a puncture.
39. The apparatus of Claim 30, wherein the ultrasonic transducer applicator includes an emitter face having an aspheric shape so that the ultrasonic energy emitted thereby is focused to encompass an area substantially greater than a site of a puncture, to ensure that the ultrasonic energy is applied to a puncture.
40. The apparatus of Claim 31 , wherein the ultrasonic transducer applicator includes an ultrasound emitter that is controlled by the processor in accord with the machine instructions to emit both the ultrasound energy employed to close and seal a puncture and the imaging ultrasound beam that is used to determine a site of a puncture.
41. The apparatus of Claim 31 , wherein the machine instructions executed by the processor further cause the processor to interrupt administration of the ultrasonic energy to a site of a puncture to generate the imaging ultrasonic beam, for again displaying an image to confirm whether the ultrasonic energy is being accurately directed to a site of a puncture.
42. The apparatus of Claim 30, wherein the ultrasonic transducer applicator further comprises a force generator that produces a pressure controlled by the processor in accord with the machine instructions executed by the processor.
43. The apparatus of Claim 42, further comprising a force sensor that monitors a force being applied against a surface of a patient, producing a signal indicative thereof that is coupled to the control, said control employing the signal to vary a pressure caused by the force generator so that the pressure is sufficient to substantially prevent a fluid leaking from a puncture, but not so great as to substantially occlude a fluid flow through a vascular vessel in which a puncture is disposed.
44. The apparatus of Claim 30, wherein the ultrasonic transducer applicator comprises an ultrasonic emitter face and a protective shell adapted to contact an external dermal portion of a patient in order to convey the ultrasonic energy transdermally to a site of a puncture, while protecting against the ultrasonic emitter face directly contacting an external dermal portion of a patient.
45. Apparatus adapted to seal a puncture in a vascular vessel of a patient, comprising:
(a) an ultrasonic transducer that controllably radiates ultrasonic energy and which is adapted to:
(i) controllably focus the ultrasonic energy on a site where a puncture is disposed in a vascular system of a patient; and
(ii) generate ultrasonic energy at an intensity sufficient to denature tissue, closing and sealing a puncture; and
(b) a protective applicator shell sized to fit over the ultrasonic transducer and including a facing surface adapted to contact an external surface of a patient's body at the site where a transdermal puncture extends into a vascular vessel of a patient, said protective applicator shell coupling the ultrasonic generated by the ultrasonic transducer into a patient's body at the site and protecting against the ultrasonic transducer directly contacting a patient while a puncture is being closed and sealed by the ultrasonic energy.
46. The apparatus of Claim 45, wherein the protective applicator shell includes an outer surface on which is disposed a patch of a gel covered by a removable tab, said patch of the gel being exposed upon removal of the tab to facilitate coupling of the ultrasound energy into a body of a patient.
47. The apparatus of Claim 45, wherein the protective applicator shell includes an interior cavity into which the ultrasonic transducer is inserted, said cavity including a layer of a gel to facilitate coupling of the ultrasonic energy produced by the ultrasonic transducer into a surface with which the protective applicator shell is in contact.
48. The apparatus of Claim 45, wherein the ultrasonic transducer includes a cable, said protective applicator shell being provided for use in a sterile state and including a protective sheath that is adapted to prevent the cable from contacting a sterile field on a body of patient against which the protective applicator shell is brought into contact to administer the ultrasonic energy.
49. The apparatus of Claim 45, wherein the ultrasonic transducer is adapted to selectively generate a broad imaging beam and a focused beam for administering the ultrasonic energy to a puncture site, said broad imaging beam being used to determine a location of a site of a puncture in a vascular vessel.
50. The apparatus of Claim 45, wherein the protective applicator shell is substantially optically transparent to enable markings and indicators included on the ultrasonic transducer to be observed by an operator using the ultrasonic transducer while the ultrasonic transducer is fitted inside the protective applicator shell.
PCT/US2000/041606 1999-10-25 2000-10-25 Use of focused ultrasound for vascular sealing WO2001034018A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2001536034A JP2003513691A (en) 1999-10-25 2000-10-25 Use of focused ultrasound to seal blood vessels
CA002387127A CA2387127A1 (en) 1999-10-25 2000-10-25 Use of focused ultrasound for vascular sealing
AU26193/01A AU2619301A (en) 1999-10-25 2000-10-25 Use of focused ultrasound for vascular sealing
EP00989717A EP1229839A4 (en) 1999-10-25 2000-10-25 Use of focused ultrasound for vascular sealing

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16346699P 1999-10-25 1999-10-25
US60/163,466 1999-10-25
US17170399P 1999-12-23 1999-12-23
US60/171,703 1999-12-23

Publications (2)

Publication Number Publication Date
WO2001034018A2 true WO2001034018A2 (en) 2001-05-17
WO2001034018A3 WO2001034018A3 (en) 2002-01-10

Family

ID=26859662

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/041606 WO2001034018A2 (en) 1999-10-25 2000-10-25 Use of focused ultrasound for vascular sealing

Country Status (6)

Country Link
US (10) US6656136B1 (en)
EP (1) EP1229839A4 (en)
JP (1) JP2003513691A (en)
AU (1) AU2619301A (en)
CA (1) CA2387127A1 (en)
WO (1) WO2001034018A2 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1427343A2 (en) * 2001-05-29 2004-06-16 Ethicon Endo-Surgery, Inc. Ultrasound-based occlusive procedure for medical treatment
WO2006021651A1 (en) 2004-07-23 2006-03-02 Inserm Ultrasound treating device and method
WO2007069156A1 (en) * 2005-12-14 2007-06-21 Koninklijke Philips Electronics, N.V. Transducer cuff for guidance and application of high intensity focused ultrasound for control of bleeding due to severed limbs
WO2007069154A1 (en) 2005-12-14 2007-06-21 Koninklijke Philips Electronics N.V. Method and apparatus for guidance and application of high intensity focused ultrasound for control of bleeding due to severed limbs
WO2008024553A1 (en) * 2006-08-24 2008-02-28 Boston Scientific Scimed, Inc. Blood vessel puncture locating apparatus and method
JP2009297527A (en) * 2002-07-25 2009-12-24 Novasys Medical Inc Apparatus and method for treating female urinary incontinence
EP2482733A1 (en) * 2009-09-29 2012-08-08 Liposonix, Inc. Variable treatment site body contouring using an ultrasound therapy device
US8295912B2 (en) 2009-10-12 2012-10-23 Kona Medical, Inc. Method and system to inhibit a function of a nerve traveling with an artery
US8374674B2 (en) 2009-10-12 2013-02-12 Kona Medical, Inc. Nerve treatment system
US8469904B2 (en) 2009-10-12 2013-06-25 Kona Medical, Inc. Energetic modulation of nerves
US8512262B2 (en) 2009-10-12 2013-08-20 Kona Medical, Inc. Energetic modulation of nerves
US8517962B2 (en) 2009-10-12 2013-08-27 Kona Medical, Inc. Energetic modulation of nerves
US8986211B2 (en) 2009-10-12 2015-03-24 Kona Medical, Inc. Energetic modulation of nerves
US8986231B2 (en) 2009-10-12 2015-03-24 Kona Medical, Inc. Energetic modulation of nerves
US8992447B2 (en) 2009-10-12 2015-03-31 Kona Medical, Inc. Energetic modulation of nerves
US9005143B2 (en) 2009-10-12 2015-04-14 Kona Medical, Inc. External autonomic modulation
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
US9144693B2 (en) 2007-06-25 2015-09-29 International Cardio Corporation Image guided plaque ablation
CN110547852A (en) * 2018-05-31 2019-12-10 柯惠有限合伙公司 method and system for ultrasonic vascular sealing
US10772681B2 (en) 2009-10-12 2020-09-15 Utsuka Medical Devices Co., Ltd. Energy delivery to intraparenchymal regions of the kidney
US10925579B2 (en) 2014-11-05 2021-02-23 Otsuka Medical Devices Co., Ltd. Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery

Families Citing this family (234)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9198635B2 (en) 1997-10-31 2015-12-01 University Of Washington Method and apparatus for preparing organs and tissues for laparoscopic surgery
US7686763B2 (en) * 1998-09-18 2010-03-30 University Of Washington Use of contrast agents to increase the effectiveness of high intensity focused ultrasound therapy
US7722539B2 (en) * 1998-09-18 2010-05-25 University Of Washington Treatment of unwanted tissue by the selective destruction of vasculature providing nutrients to the tissue
US7510536B2 (en) 1999-09-17 2009-03-31 University Of Washington Ultrasound guided high intensity focused ultrasound treatment of nerves
US7520856B2 (en) 1999-09-17 2009-04-21 University Of Washington Image guided high intensity focused ultrasound device for therapy in obstetrics and gynecology
AU2619301A (en) 1999-10-25 2001-06-06 Therus Corporation Use of focused ultrasound for vascular sealing
US6626855B1 (en) 1999-11-26 2003-09-30 Therus Corpoation Controlled high efficiency lesion formation using high intensity ultrasound
WO2001045550A2 (en) * 1999-12-23 2001-06-28 Therus Corporation Ultrasound transducers for imaging and therapy
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US6743195B2 (en) * 2001-03-14 2004-06-01 Cardiodex Balloon method and apparatus for vascular closure following arterial catheterization
US6951542B2 (en) * 2002-06-26 2005-10-04 Esaote S.P.A. Method and apparatus for ultrasound imaging of a biopsy needle or the like during an ultrasound imaging examination
US7511704B2 (en) * 2001-11-20 2009-03-31 Illinois Tool Works Inc. Acoustic wave touch bar system and method of use
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US20040082859A1 (en) 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
US20060267255A1 (en) * 2003-01-31 2006-11-30 Daniela Tomova Process for producing a performance enhanced single-layer blow-moulded container
US7115127B2 (en) 2003-02-04 2006-10-03 Cardiodex, Ltd. Methods and apparatus for hemostasis following arterial catheterization
US7223266B2 (en) 2003-02-04 2007-05-29 Cardiodex Ltd. Methods and apparatus for hemostasis following arterial catheterization
JP2007504910A (en) 2003-09-12 2007-03-08 ミノウ・メディカル・エルエルシイ Selectable biased reshaping and / or excision of atherosclerotic material
US8211017B2 (en) 2003-12-16 2012-07-03 University Of Washington Image guided high intensity focused ultrasound treatment of nerves
EP1711106A2 (en) 2004-01-20 2006-10-18 Therus Corporation Interface for use between medical instrumentation and a patient
US7662114B2 (en) 2004-03-02 2010-02-16 Focus Surgery, Inc. Ultrasound phased arrays
US20070219448A1 (en) * 2004-05-06 2007-09-20 Focus Surgery, Inc. Method and Apparatus for Selective Treatment of Tissue
WO2005112772A2 (en) * 2004-05-07 2005-12-01 Johns Hopkins University Ultrasound strain imaging in tissue therapies
US20050267520A1 (en) 2004-05-12 2005-12-01 Modesitt D B Access and closure device and method
US7678133B2 (en) * 2004-07-10 2010-03-16 Arstasis, Inc. Biological tissue closure device and method
US9066679B2 (en) 2004-08-31 2015-06-30 University Of Washington Ultrasonic technique for assessing wall vibrations in stenosed blood vessels
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
JP4690832B2 (en) * 2004-09-14 2011-06-01 株式会社東芝 Ultrasonic probe diagnostic apparatus, ultrasonic diagnostic apparatus, and ultrasonic probe diagnostic method
WO2006032059A2 (en) 2004-09-16 2006-03-23 University Of Washington Acoustic coupler using an independent water pillow with circulation for cooling a transducer
WO2006032058A2 (en) * 2004-09-16 2006-03-23 University Of Washington Interference-free ultrasound imaging during hifu therapy, using software tools
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US8690778B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Energy-based tissue tightening
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
KR101605527B1 (en) 2004-10-06 2016-03-22 가이디드 테라피 시스템스, 엘.엘.씨. Ultrasound treatment system
US8663112B2 (en) 2004-10-06 2014-03-04 Guided Therapy Systems, Llc Methods and systems for fat reduction and/or cellulite treatment
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
EP1879502A2 (en) 2004-10-06 2008-01-23 Guided Therapy Systems, L.L.C. Method and system for cosmetic enhancement
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
JP5068662B2 (en) 2004-11-22 2012-11-07 カーディオデックス リミテッド Heat treatment technology for varicose veins
US7553284B2 (en) * 2005-02-02 2009-06-30 Vaitekunas Jeffrey J Focused ultrasound for pain reduction
US20060241527A1 (en) * 2005-03-03 2006-10-26 Robert Muratore System and method for inducing controlled cardiac damage
EP2438877B1 (en) 2005-03-28 2016-02-17 Vessix Vascular, Inc. Intraluminal electrical tissue characterization and tuned RF energy for selective treatment of atheroma and other target tissues
AU2006247355B2 (en) 2005-05-12 2013-01-10 Arstasis, Inc. Access and closure device and method
EP1885248B1 (en) * 2005-05-12 2014-12-31 Compumedics Medical Innovations Pty Ltd Ultrasound diagnosis and treatment apparatus
US8038631B1 (en) 2005-06-01 2011-10-18 Sanghvi Narendra T Laparoscopic HIFU probe
JP4686269B2 (en) * 2005-06-22 2011-05-25 株式会社日立メディコ Ultrasonic therapy device
US20070038096A1 (en) * 2005-07-06 2007-02-15 Ralf Seip Method of optimizing an ultrasound transducer
US20070010805A1 (en) 2005-07-08 2007-01-11 Fedewa Russell J Method and apparatus for the treatment of tissue
US7591996B2 (en) * 2005-08-17 2009-09-22 University Of Washington Ultrasound target vessel occlusion using microbubbles
US7621873B2 (en) * 2005-08-17 2009-11-24 University Of Washington Method and system to synchronize acoustic therapy with ultrasound imaging
US7824397B2 (en) 2005-08-19 2010-11-02 Boston Scientific Scimed, Inc. Occlusion apparatus
WO2007035529A2 (en) 2005-09-16 2007-03-29 University Of Washington Thin-profile therapeutic ultrasound applicators
US8057408B2 (en) 2005-09-22 2011-11-15 The Regents Of The University Of Michigan Pulsed cavitational ultrasound therapy
US10219815B2 (en) * 2005-09-22 2019-03-05 The Regents Of The University Of Michigan Histotripsy for thrombolysis
US20070083120A1 (en) * 2005-09-22 2007-04-12 Cain Charles A Pulsed cavitational ultrasound therapy
US8016757B2 (en) 2005-09-30 2011-09-13 University Of Washington Non-invasive temperature estimation technique for HIFU therapy monitoring using backscattered ultrasound
US20070088346A1 (en) * 2005-10-14 2007-04-19 Mirizzi Michael S Method and apparatus for varicose vein treatment using acoustic hemostasis
US20070213616A1 (en) * 2005-10-20 2007-09-13 Thomas Anderson Systems and methods for arteriotomy localization
KR100875208B1 (en) * 2005-12-09 2008-12-19 주식회사 메디슨 High intensity focus ultrasound system
US20070149880A1 (en) * 2005-12-22 2007-06-28 Boston Scientific Scimed, Inc. Device and method for determining the location of a vascular opening prior to application of HIFU energy to seal the opening
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
WO2007132449A2 (en) * 2006-05-11 2007-11-22 Yossi Gross Implantable respiration therapy device
US20080039746A1 (en) 2006-05-25 2008-02-14 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US8118743B2 (en) * 2006-05-26 2012-02-21 Ultrasound Ventures, Llc Sterile cover
US20080039724A1 (en) * 2006-08-10 2008-02-14 Ralf Seip Ultrasound transducer with improved imaging
US7789893B2 (en) * 2006-09-12 2010-09-07 Boston Scientific Scimed, Inc. Method and apparatus for promoting hemostasis of a blood vessel puncture
WO2008033528A2 (en) * 2006-09-13 2008-03-20 Acoustx Corporation Therapeutic and diagnostic electrostrictor ultrasonic arrays
US7559905B2 (en) 2006-09-21 2009-07-14 Focus Surgery, Inc. HIFU probe for treating tissue with in-line degassing of fluid
AU2007310991B2 (en) 2006-10-18 2013-06-20 Boston Scientific Scimed, Inc. System for inducing desirable temperature effects on body tissue
WO2008049082A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. Inducing desirable temperature effects on body tissue
EP2954868A1 (en) 2006-10-18 2015-12-16 Vessix Vascular, Inc. Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
US7985254B2 (en) 2007-01-08 2011-07-26 David Tolkowsky Endobronchial fluid exhaler devices and methods for use thereof
US8496653B2 (en) 2007-04-23 2013-07-30 Boston Scientific Scimed, Inc. Thrombus removal
US8003157B2 (en) 2007-06-15 2011-08-23 Abbott Cardiovascular Systems Inc. System and method for coating a stent
US8677650B2 (en) * 2007-06-15 2014-03-25 Abbott Cardiovascular Systems Inc. Methods and devices for drying coated stents
US8366706B2 (en) 2007-08-15 2013-02-05 Cardiodex, Ltd. Systems and methods for puncture closure
JP2009050372A (en) * 2007-08-24 2009-03-12 Ge Medical Systems Global Technology Co Llc Ultrasonic diagnostic apparatus
US8235902B2 (en) 2007-09-11 2012-08-07 Focus Surgery, Inc. System and method for tissue change monitoring during HIFU treatment
US8241324B2 (en) * 2008-03-03 2012-08-14 Eilaz Babaev Ultrasonic vascular closure device
ES2358248B1 (en) * 2008-04-02 2012-03-01 S.O.R. Internacional, S.A. PROCEDURE FOR THE MANUFACTURE OF A RADIANT SURFACE OF A PIEZOELECTRIC CERAMIC.
US20090254005A1 (en) * 2008-04-03 2009-10-08 Eilaz Babaev Ultrasound assisted tissue welding device
KR102147455B1 (en) 2008-06-06 2020-08-24 얼테라, 인크 Ultrasound treatment system
US8149093B2 (en) * 2008-06-06 2012-04-03 Lyngsoe Systems System and method for wireless communications
CN102159126A (en) 2008-07-21 2011-08-17 阿尔斯塔西斯公司 Devices, methods, and kits for forming tracts in tissue
WO2010019481A1 (en) 2008-08-11 2010-02-18 Conceptx Medical, Inc. Systems and methods for treating dyspnea, including via electrical afferent signal blocking
CN102271603A (en) 2008-11-17 2011-12-07 明诺医学股份有限公司 Selective accumulation of energy with or without knowledge of tissue topography
EP2376011B1 (en) 2009-01-09 2019-07-03 ReCor Medical, Inc. Apparatus for treatment of mitral valve insufficiency
EP2427117B1 (en) 2009-05-07 2019-10-09 Hitachi, Ltd. Ultrasound instrument for orthopedic applications
US8206306B2 (en) * 2009-05-07 2012-06-26 Hitachi Aloka Medical, Ltd. Ultrasound systems and methods for orthopedic applications
US8551096B2 (en) 2009-05-13 2013-10-08 Boston Scientific Scimed, Inc. Directional delivery of energy and bioactives
AU2010284313B2 (en) 2009-08-17 2016-01-28 Histosonics, Inc. Disposable acoustic coupling medium container
EP2470087B1 (en) 2009-08-26 2015-03-25 The Regents Of The University Of Michigan Devices for using controlled bubble cloud cavitation in fractionating urinary stones
WO2011028603A2 (en) * 2009-08-26 2011-03-10 The Regents Of The University Of Michigan Micromanipulator control arm for therapeutic and imaging ultrasound transducers
CN102497822B (en) 2009-09-17 2015-02-11 皇家飞利浦电子股份有限公司 Medical ultrasound device with temperature detection at distal end
CN102933153A (en) 2010-01-29 2013-02-13 弗吉尼亚大学专利基金会 Ultrasound for locating anatomy or probe guidance
EP2555699B1 (en) 2010-04-09 2019-04-03 Vessix Vascular, Inc. Power generating and control apparatus for the treatment of tissue
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US10117564B2 (en) 2010-04-16 2018-11-06 Hitachi Healthcare Americas Corporation Ultrasound and detachable instrument for procedures
KR101875203B1 (en) 2010-06-09 2018-07-06 리전츠 오브 더 유니버스티 오브 미네소타 Dual mode ultrasound transducer (dmut) system and method for controlling delivery of ultrasound therapy
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US8702592B2 (en) 2010-09-30 2014-04-22 David Allan Langlois System and method for inhibiting injury to a patient during laparoscopic surgery
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US20120109021A1 (en) * 2010-10-27 2012-05-03 Roger Hastings Renal denervation catheter employing acoustic wave generator arrangement
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9326751B2 (en) * 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
AU2011329669B2 (en) * 2010-11-19 2016-07-28 Boston Scientific Scimed, Inc. Renal nerve detection and ablation apparatus and method
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US11045246B1 (en) 2011-01-04 2021-06-29 Alan N. Schwartz Apparatus for effecting feedback of vaginal cavity physiology
US9521966B2 (en) 2012-05-17 2016-12-20 Alan N. Schwartz Localization of the parathyroid
US20130019374A1 (en) 2011-01-04 2013-01-24 Schwartz Alan N Gel-based seals and fixation devices and associated systems and methods
US9220561B2 (en) 2011-01-19 2015-12-29 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
EP2696771B8 (en) 2011-04-14 2018-11-28 Regents of the University of Minnesota Vascular characterization using ultrasound imaging
JP6057985B2 (en) * 2011-04-26 2017-01-11 ユニバーシティ オブ バージニア パテント ファウンデーション Bone surface image reconstruction using ultrasound
US10117705B2 (en) * 2011-05-16 2018-11-06 Covidien Lp Optical recognition of tissue and vessels
US9028470B2 (en) * 2011-06-17 2015-05-12 University Of Utah Research Foundation Image-guided renal nerve ablation
AU2012283908B2 (en) 2011-07-20 2017-02-16 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
AU2012287189B2 (en) 2011-07-22 2016-10-06 Boston Scientific Scimed, Inc. Nerve modulation system with a nerve modulation element positionable in a helical guide
US9144694B2 (en) 2011-08-10 2015-09-29 The Regents Of The University Of Michigan Lesion generation through bone using histotripsy therapy without aberration correction
WO2013044166A1 (en) 2011-09-23 2013-03-28 Schwartz Alan N Non-invasive and minimally invasive and tightly targeted minimally invasive therapy methods and devices for parathyroid treatment
US9186210B2 (en) 2011-10-10 2015-11-17 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
WO2013055815A1 (en) 2011-10-11 2013-04-18 Boston Scientific Scimed, Inc. Off -wall electrode device for nerve modulation
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
EP2768568B1 (en) 2011-10-18 2020-05-06 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
EP2768563B1 (en) 2011-10-18 2016-11-09 Boston Scientific Scimed, Inc. Deflectable medical devices
CN104023662B (en) 2011-11-08 2018-02-09 波士顿科学西美德公司 Hole portion renal nerve melts
US9119600B2 (en) 2011-11-15 2015-09-01 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9107737B2 (en) 2011-11-21 2015-08-18 Alan Schwartz Goggles with facial conforming eyepieces
KR102067583B1 (en) 2011-12-09 2020-01-17 메타벤션, 인크. Therapeutic neuromodulation of the hepatic system
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
EP3138521B1 (en) 2011-12-23 2019-05-29 Vessix Vascular, Inc. Apparatuses for remodeling tissue of or adjacent to a body passage
US9433760B2 (en) 2011-12-28 2016-09-06 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
JP5962018B2 (en) 2012-01-11 2016-08-03 セイコーエプソン株式会社 Ultrasonic transducers, ultrasonic probes, diagnostic equipment and electronic equipment
US9049783B2 (en) 2012-04-13 2015-06-02 Histosonics, Inc. Systems and methods for obtaining large creepage isolation on printed circuit boards
KR101356431B1 (en) * 2012-04-17 2014-01-29 주식회사 하이로닉 High intensity focused ultrasound generating device for deduction of fat tissue
CN107693114A (en) 2012-04-24 2018-02-16 西比姆公司 The catheter in blood vessel and method extractd for carotid body
KR101356437B1 (en) * 2012-04-27 2014-02-11 주식회사 하이로닉 High intensity focused ultrasound generating device for deduction of fat tissue
EP2844343B1 (en) 2012-04-30 2018-11-21 The Regents Of The University Of Michigan Ultrasound transducer manufacturing using rapid-prototyping method
WO2013169927A1 (en) 2012-05-08 2013-11-14 Boston Scientific Scimed, Inc. Renal nerve modulation devices
TWI702955B (en) 2012-05-15 2020-09-01 澳大利亞商艾佛蘭屈澳洲私營有限公司 Treatment of amd using aav sflt-1
US20130317481A1 (en) 2012-05-25 2013-11-28 Arstasis, Inc. Vascular access configuration
US20130317438A1 (en) 2012-05-25 2013-11-28 Arstasis, Inc. Vascular access configuration
US9398930B2 (en) 2012-06-01 2016-07-26 Cibiem, Inc. Percutaneous methods and devices for carotid body ablation
WO2013181660A1 (en) 2012-06-01 2013-12-05 Cibiem, Inc. Methods and devices for cryogenic carotid body ablation
EP2866669A4 (en) 2012-06-30 2016-04-20 Cibiem Inc Carotid body ablation via directed energy
US9955946B2 (en) 2014-03-12 2018-05-01 Cibiem, Inc. Carotid body ablation with a transvenous ultrasound imaging and ablation catheter
WO2014032016A1 (en) 2012-08-24 2014-02-27 Boston Scientific Scimed, Inc. Intravascular catheter with a balloon comprising separate microporous regions
CN104780859B (en) 2012-09-17 2017-07-25 波士顿科学西美德公司 Self-positioning electrode system and method for renal regulation
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
WO2014047411A1 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
WO2014047454A2 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
EP2903688A4 (en) 2012-10-05 2016-06-15 Univ Michigan Bubble-induced color doppler feedback during histotripsy
US10835305B2 (en) 2012-10-10 2020-11-17 Boston Scientific Scimed, Inc. Renal nerve modulation devices and methods
CN104027893B (en) 2013-03-08 2021-08-31 奥赛拉公司 Apparatus and method for multi-focal ultrasound therapy
WO2014164363A1 (en) * 2013-03-09 2014-10-09 Kona Medical, Inc. Transducers, systems, and manufacturing techniques for focused ultrasound therapies
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
WO2014163987A1 (en) 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
JP6220044B2 (en) 2013-03-15 2017-10-25 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for renal nerve ablation
AU2014237950B2 (en) 2013-03-15 2017-04-13 Boston Scientific Scimed, Inc. Control unit for use with electrode pads and a method for estimating an electrical leakage
EP2968919B1 (en) 2013-03-15 2021-08-25 Medtronic Ardian Luxembourg S.à.r.l. Controlled neuromodulation systems
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
JP6440682B2 (en) * 2013-03-28 2018-12-19 ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャリゼーション Focused ultrasound equipment and method of use
WO2014205399A1 (en) 2013-06-21 2014-12-24 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation having rotatable shafts
WO2014205388A1 (en) 2013-06-21 2014-12-24 Boston Scientific Scimed, Inc. Renal denervation balloon catheter with ride along electrode support
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
EP3016605B1 (en) 2013-07-01 2019-06-05 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
BR112015032926B1 (en) 2013-07-03 2022-04-05 Histosonics, Inc. ULTRASOUND THERAPY SYSTEM
US11432900B2 (en) 2013-07-03 2022-09-06 Histosonics, Inc. Articulating arm limiter for cavitational ultrasound therapy system
CN105377170A (en) 2013-07-11 2016-03-02 波士顿科学国际有限公司 Medical device with stretchable electrode assemblies
US10660698B2 (en) 2013-07-11 2020-05-26 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
CN105682594B (en) 2013-07-19 2018-06-22 波士顿科学国际有限公司 Helical bipolar electrodes renal denervation dominates air bag
WO2015013205A1 (en) 2013-07-22 2015-01-29 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
WO2015013301A1 (en) 2013-07-22 2015-01-29 Boston Scientific Scimed, Inc. Renal nerve ablation catheter having twist balloon
EP3025166B1 (en) 2013-07-23 2020-06-17 Regents of the University of Minnesota Ultrasound image formation and/or reconstruction using multiple frequency waveforms
CN105518482B (en) 2013-08-19 2019-07-30 Bk医疗控股股份有限公司 Ultrasonic imaging instrument visualization
EP4049605A1 (en) 2013-08-22 2022-08-31 Boston Scientific Scimed Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
WO2015027164A1 (en) 2013-08-22 2015-02-26 The Regents Of The University Of Michigan Histotripsy using very short ultrasound pulses
CN105555218B (en) 2013-09-04 2019-01-15 波士顿科学国际有限公司 With radio frequency (RF) foley's tube rinsed with cooling capacity
CN105530885B (en) 2013-09-13 2020-09-22 波士顿科学国际有限公司 Ablation balloon with vapor deposited covering
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
CN105636537B (en) 2013-10-15 2018-08-17 波士顿科学国际有限公司 Medical instrument sacculus
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
EP3057521B1 (en) 2013-10-18 2020-03-25 Boston Scientific Scimed, Inc. Balloon catheters with flexible conducting wires
US10271898B2 (en) 2013-10-25 2019-04-30 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
CN105899157B (en) 2014-01-06 2019-08-09 波士顿科学国际有限公司 Tear-proof flexible circuit assembly
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
CN106572881B (en) 2014-02-04 2019-07-26 波士顿科学国际有限公司 Substitution of the heat sensor on bipolar electrode is placed
CN106414474B (en) 2014-03-17 2021-01-15 阿德夫拉姆生物技术股份有限公司 Compositions and methods for enhanced gene expression in cone cells
WO2015144811A1 (en) * 2014-03-26 2015-10-01 Koninklijke Philips N.V. Rheology system and mr rheology system with rheology sensor feedback control
EP3131630B1 (en) 2014-04-18 2023-11-29 Ulthera, Inc. Band transducer ultrasound therapy
US11382515B2 (en) 2014-08-07 2022-07-12 Verve Medical, Inc. Renal denervation using nerve fluorescing dye
AU2016226289B2 (en) 2015-03-02 2021-04-29 Adverum Biotechnologies, Inc. Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
WO2016205824A1 (en) 2015-06-19 2016-12-22 Neural Analytics, Inc. Transcranial doppler probe
ES2948135T3 (en) 2015-06-24 2023-08-31 Univ Michigan Regents Histotripsy therapy systems for the treatment of brain tissue
GB2545763A (en) 2015-12-23 2017-06-28 Adverum Biotechnologies Inc Mutant viral capsid libraries and related systems and methods
US11090026B2 (en) 2016-01-05 2021-08-17 Novasignal Corp. Systems and methods for determining clinical indications
US11589836B2 (en) 2016-01-05 2023-02-28 Novasignal Corp. Systems and methods for detecting neurological conditions
EP3399920B1 (en) 2016-01-05 2020-11-04 Neural Analytics, Inc. Integrated probe structure
IL259944B (en) 2016-01-18 2022-07-01 Ulthera Inc Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
US10524859B2 (en) 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods
BR112018072101B1 (en) 2016-08-16 2024-01-02 Ulthera, Inc SYSTEMS AND METHODS FOR COSMETIC SKIN TREATMENT WITH ULTRASOUND
FR3072577B1 (en) * 2017-10-23 2019-09-27 Cardiawave Sa APPARATUS FOR TREATING VASCULAR THROMBOSIS BY ULTRASOUND
US11458337B2 (en) 2017-11-28 2022-10-04 Regents Of The University Of Minnesota Adaptive refocusing of ultrasound transducer arrays using image data
US11596812B2 (en) 2018-04-06 2023-03-07 Regents Of The University Of Minnesota Wearable transcranial dual-mode ultrasound transducers for neuromodulation
WO2020113083A1 (en) 2018-11-28 2020-06-04 Histosonics, Inc. Histotripsy systems and methods
AU2021213168A1 (en) 2020-01-28 2022-09-01 The Regents Of The University Of Michigan Systems and methods for histotripsy immunosensitization
JP7242621B2 (en) * 2020-10-27 2023-03-20 ジーイー・プレシジョン・ヘルスケア・エルエルシー Ultrasound image display system and its control program
CN114112305B (en) * 2021-12-06 2024-02-06 西南石油大学 Device and method for testing fluid-solid coupling effect of flexible riser by internal and external flow clamping

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5383896A (en) * 1993-05-25 1995-01-24 Gershony; Gary Vascular sealing device
US5810810A (en) * 1992-04-23 1998-09-22 Scimed Life Systems, Inc. Apparatus and method for sealing vascular punctures
US6007499A (en) * 1997-10-31 1999-12-28 University Of Washington Method and apparatus for medical procedures using high-intensity focused ultrasound

Family Cites Families (360)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US558092A (en) * 1896-04-14 Automatic railway-gate
US385256A (en) 1888-06-26 eggers
US3274437A (en) 1963-11-20 1966-09-20 Thompson Ramo Wooldridge Inc High intensity radiant energy source
US3499437A (en) * 1967-03-10 1970-03-10 Ultrasonic Systems Method and apparatus for treatment of organic structures and systems thereof with ultrasonic energy
US3552382A (en) * 1968-01-11 1971-01-05 Hoffmann La Roche Ultrasonic transducer assembly for biological inspections
US3927662A (en) 1971-12-08 1975-12-23 Hoffmann La Roche Ultrasonic transducer assembly
US3847016A (en) 1971-12-08 1974-11-12 Hoffmann La Roche Ultrasonic transducer assembly
US4167180A (en) 1975-05-01 1979-09-11 The Commonwealth Of Australia, Care Of The Department Of Health Method and apparatus for ultrasonic examination
US4059098A (en) 1975-07-21 1977-11-22 Stanford Research Institute Flexible ultrasound coupling system
US4197856A (en) * 1978-04-10 1980-04-15 Northrop Robert B Ultrasonic respiration/convulsion monitoring apparatus and method for its use
US4206763A (en) * 1978-08-01 1980-06-10 Drexel University Ultrasonic scanner for breast cancer examination
US4237901A (en) * 1978-08-30 1980-12-09 Picker Corporation Low and constant pressure transducer probe for ultrasonic diagnostic system
US4273127A (en) * 1978-10-12 1981-06-16 Research Corporation Method for cutting and coagulating tissue
US4315514A (en) * 1980-05-08 1982-02-16 William Drewes Method and apparatus for selective cell destruction
US4469099A (en) 1980-10-02 1984-09-04 Western Clinical Engineering Ltd. Pneumatic torniquet
US4484569A (en) * 1981-03-13 1984-11-27 Riverside Research Institute Ultrasonic diagnostic and therapeutic transducer assembly and method for using
US4479494A (en) 1982-01-05 1984-10-30 Western Clinical Engineering Ltd. Adaptive pneumatic tourniquet
DE3219271A1 (en) 1982-05-21 1983-11-24 Siemens AG, 1000 Berlin und 8000 München ULTRASONIC APPLICATOR
JPS59147508U (en) 1983-03-25 1984-10-02 株式会社東芝 Ultrasonic probe adapter
JPS6080442A (en) * 1983-10-06 1985-05-08 テルモ株式会社 Ultrasonic measuring method and apparatus
US4601296A (en) 1983-10-07 1986-07-22 Yeda Research And Development Co., Ltd. Hyperthermia apparatus
US5150712A (en) 1983-12-14 1992-09-29 Edap International, S.A. Apparatus for examining and localizing tumors using ultra sounds, comprising a device for localized hyperthermia treatment
USRE33590E (en) 1983-12-14 1991-05-21 Edap International, S.A. Method for examining, localizing and treating with ultrasound
US5143073A (en) * 1983-12-14 1992-09-01 Edap International, S.A. Wave apparatus system
US4605010A (en) 1984-05-17 1986-08-12 Western Clinical Engineering Ltd. Pressurizing cuff
JPS61209643A (en) 1985-03-15 1986-09-17 株式会社東芝 Ultrasonic diagnostic and medical treatment apparatus
EP0195718A1 (en) 1985-03-22 1986-09-24 Commissariat A L'energie Atomique Artificial skull, prosthetic head built up from the skull and process for producing them
JPH0653120B2 (en) * 1985-05-10 1994-07-20 オリンパス光学工業株式会社 Ultrasonic diagnostic equipment
GB8529446D0 (en) 1985-11-29 1986-01-08 Univ Aberdeen Divergent ultrasound arrays
DE3544344A1 (en) * 1985-12-14 1987-06-19 Dornier Medizintechnik DEVICE FOR TROMBOISING BY SHOCK WAVE
US4784148A (en) * 1986-02-21 1988-11-15 Johnson & Johnson Ultrasonic transducer probe expansion chamber
US5000185A (en) * 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
DE3787746T2 (en) 1986-04-02 1994-02-17 Matsushita Electric Ind Co Ltd Ultrasound transducer with an ultrasound propagation medium.
JPH074373B2 (en) * 1986-10-16 1995-01-25 オリンパス光学工業株式会社 Ultrasound endoscopy
US4770175A (en) 1986-10-22 1988-09-13 Western Clinical Engineering Ltd. Occlusive cuff
DE3704909A1 (en) * 1987-02-17 1988-08-25 Wolf Gmbh Richard DEVICE FOR SPACIOUS LOCATION AND DESTRUCTION OF INTERIOR OBJECTS WITH ULTRASOUND
US5181522A (en) * 1987-04-03 1993-01-26 Abatis Medical Technologies Limited Tourniquet for sensing and regulation of applied pressure
US5178135A (en) * 1987-04-16 1993-01-12 Olympus Optical Co., Ltd. Therapeutical apparatus of extracorporeal type
US4913155A (en) * 1987-05-11 1990-04-03 Capistrano Labs, Inc. Ultrasonic transducer probe assembly
US4773865A (en) 1987-06-26 1988-09-27 Baldwin Jere F Training mannequin
US4931047A (en) * 1987-09-30 1990-06-05 Cavitron, Inc. Method and apparatus for providing enhanced tissue fragmentation and/or hemostasis
US4841979A (en) 1988-01-25 1989-06-27 Capistrano Labs, Inc. Ultrasonic prostate probe assembly
US4957099A (en) * 1988-02-10 1990-09-18 Siemens Aktiengesellschaft Shock wave source for extracorporeal lithotripsy
US5036855A (en) * 1988-03-02 1991-08-06 Laboratory Equipment, Corp. Localization and therapy system for treatment of spatially oriented focal disease
US4858613A (en) 1988-03-02 1989-08-22 Laboratory Equipment, Corp. Localization and therapy system for treatment of spatially oriented focal disease
US5522878A (en) 1988-03-25 1996-06-04 Lectec Corporation Solid multipurpose ultrasonic biomedical couplant gel in sheet form and method
US4966953A (en) 1988-06-02 1990-10-30 Takiron Co., Ltd. Liquid segment polyurethane gel and couplers for ultrasonic diagnostic probe comprising the same
US4938217A (en) * 1988-06-21 1990-07-03 Massachusetts Institute Of Technology Electronically-controlled variable focus ultrasound hyperthermia system
US4938216A (en) 1988-06-21 1990-07-03 Massachusetts Institute Of Technology Mechanically scanned line-focus ultrasound hyperthermia system
US5211160A (en) 1988-09-14 1993-05-18 Interpore Orthopaedics, Inc. Ultrasonic orthopedic treatment head and body-mounting means therefor
US4929246A (en) * 1988-10-27 1990-05-29 C. R. Bard, Inc. Method for closing and sealing an artery after removing a catheter
JPH02217000A (en) 1989-02-16 1990-08-29 Hitachi Ltd Ultrasonic wave probe
FR2643252B1 (en) 1989-02-21 1991-06-07 Technomed Int Sa APPARATUS FOR THE SELECTIVE DESTRUCTION OF CELLS INCLUDING SOFT TISSUES AND BONES WITHIN THE BODY OF A LIVING BODY BY IMPLOSION OF GAS BUBBLES
DE3922641A1 (en) 1989-07-10 1991-01-24 Wolf Gmbh Richard RUN FOR A LITHOTRIPSY DEVICE
EP0420758B1 (en) 1989-09-29 1995-07-26 Terumo Kabushiki Kaisha Ultrasonic coupler and method for production thereof
EP0419729A1 (en) 1989-09-29 1991-04-03 Siemens Aktiengesellschaft Position finding of a catheter by means of non-ionising fields
DE4110308A1 (en) 1989-10-10 1992-10-01 Schubert Werner Hyperbaric medical breathing mask - is used for treating disorders which result in excess lipid in body tissue, and completely surrounds patients head
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US6551576B1 (en) * 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5607447A (en) 1993-09-28 1997-03-04 Mcewen; James A. Physiologic tourniquet
US5556415A (en) 1990-01-29 1996-09-17 Mcewen; James A. Physiologic tourniquet for intravenous regional anesthesia
US5254087A (en) 1990-01-29 1993-10-19 Ivra Systems, Inc. Tourniquet apparatus for intravenous regional anesthesia
US5584853A (en) 1990-01-29 1996-12-17 Mcewen; James A. Tourniquet cuff apparatus
US5026387A (en) * 1990-03-12 1991-06-25 Ultracision Inc. Method and apparatus for ultrasonic surgical cutting and hemostatis
US5263957A (en) * 1990-03-12 1993-11-23 Ultracision Inc. Ultrasonic scalpel blade and methods of application
US5311869A (en) 1990-03-24 1994-05-17 Kabushiki Kaisha Toshiba Method and apparatus for ultrasonic wave treatment in which medical progress may be evaluated
FR2660543B1 (en) * 1990-04-06 1998-02-13 Technomed Int Sa METHOD FOR AUTOMATICALLY MEASURING THE VOLUME OF A TUMOR, IN PARTICULAR A PROSTATE TUMOR, MEASURING DEVICE, METHOD AND APPARATUS COMPRISING THE SAME.
FR2660732B1 (en) 1990-04-06 1992-09-04 Technomed Int Sa TRANSLATABLE END ARM AND THERAPEUTIC TREATMENT APPARATUS, INCLUDING APPLICATION.
WO1991019529A1 (en) 1990-06-15 1991-12-26 Cortrak Medical, Inc. Drug delivery apparatus and method
US5215680A (en) 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
FR2672486A1 (en) * 1991-02-11 1992-08-14 Technomed Int Sa Ultrasound apparatus for extracorporeal therapeutic treatment of superficial varicose veins
EP0572526A4 (en) * 1991-02-13 1995-12-06 Interface Biomedical Lab Corp Filler material for use in tissue welding
US5316000A (en) * 1991-03-05 1994-05-31 Technomed International (Societe Anonyme) Use of at least one composite piezoelectric transducer in the manufacture of an ultrasonic therapy apparatus for applying therapy, in a body zone, in particular to concretions, to tissue, or to bones, of a living being and method of ultrasonic therapy
US5243988A (en) * 1991-03-13 1993-09-14 Scimed Life Systems, Inc. Intravascular imaging apparatus and methods for use and manufacture
US5194291A (en) * 1991-04-22 1993-03-16 General Atomics Corona discharge treatment
US5233994A (en) * 1991-05-13 1993-08-10 Advanced Technology Laboratories, Inc. Detection of tissue abnormality through blood perfusion differentiation
US5307816A (en) 1991-08-21 1994-05-03 Kabushiki Kaisha Toshiba Thrombus resolving treatment apparatus
US5348552A (en) * 1991-08-30 1994-09-20 Hoya Corporation Laser surgical unit
US6875420B1 (en) 1991-09-17 2005-04-05 Amersham Health As Method of ultrasound imaging
US5649954A (en) 1991-09-30 1997-07-22 Mcewen; James A. Tourniquet cuff system
US5312431A (en) 1991-09-30 1994-05-17 Abatis Medical Technologies Limited Occlusive cuff
US5741295A (en) * 1991-09-30 1998-04-21 James A. McEwen Overlapping tourniquet cuff system
US5704361A (en) * 1991-11-08 1998-01-06 Mayo Foundation For Medical Education And Research Volumetric image ultrasound transducer underfluid catheter system
US5713363A (en) * 1991-11-08 1998-02-03 Mayo Foundation For Medical Education And Research Ultrasound catheter and method for imaging and hemodynamic monitoring
US5524620A (en) 1991-11-12 1996-06-11 November Technologies Ltd. Ablation of blood thrombi by means of acoustic energy
AU2978892A (en) 1991-12-02 1993-06-10 Nitto Denko Corporation Crosslinked molding, sound medium using it and ultrasonic coupler
ATE144124T1 (en) * 1991-12-20 1996-11-15 Technomed Medical Systems DEVICE FOR ULTRASONIC THERAPY EMITTING SOUND WAVES, THERMAL EFFECTS AND CAVITATION EFFECTS
US5230334A (en) 1992-01-22 1993-07-27 Summit Technology, Inc. Method and apparatus for generating localized hyperthermia
AU3727993A (en) * 1992-02-21 1993-09-13 Diasonics Inc. Ultrasound intracavity system for imaging therapy planning and treatment of focal disease
US5993389A (en) * 1995-05-22 1999-11-30 Ths International, Inc. Devices for providing acoustic hemostasis
WO1993021844A1 (en) * 1992-04-23 1993-11-11 Scimed Life Systems, Inc. Apparatus and method for sealing vascular punctures
US5230921A (en) 1992-08-04 1993-07-27 Blacktoe Medical, Inc. Flexible piezo-electric membrane
DE4230415A1 (en) 1992-09-11 1994-03-17 Csb Syst Software Entwicklung Ultrasonic thickness measurement system e.g. for fat and muscle - includes piezoelectric crystals and ultrasonic processing circuits for imaging of organs and different layers of tissue
US5415657A (en) * 1992-10-13 1995-05-16 Taymor-Luria; Howard Percutaneous vascular sealing method
US5290278A (en) * 1992-10-20 1994-03-01 Proclosure Inc. Method and apparatus for applying thermal energy to luminal tissue
US5391197A (en) * 1992-11-13 1995-02-21 Dornier Medical Systems, Inc. Ultrasound thermotherapy probe
US5364389A (en) * 1992-11-25 1994-11-15 Premier Laser Systems, Inc. Method and apparatus for sealing and/or grasping luminal tissue
US20020095164A1 (en) * 1997-06-26 2002-07-18 Andreas Bernard H. Device and method for suturing tissue
US5738635A (en) * 1993-01-22 1998-04-14 Technomed Medical Systems Adjustable focusing therapeutic apparatus with no secondary focusing
US5573497A (en) 1994-11-30 1996-11-12 Technomed Medical Systems And Institut National High-intensity ultrasound therapy method and apparatus with controlled cavitation effect and reduced side lobes
DE4302538C1 (en) 1993-01-29 1994-04-07 Siemens Ag Ultrasonic therapy device for tumour treatment lithotripsy or osteorestoration - with ultrasonic imaging and ultrasonic treatment modes using respective acoustic wave frequencies
DE4302537C1 (en) * 1993-01-29 1994-04-28 Siemens Ag Ultrasound imaging and therapy device - generates imaging waves and focussed treatment waves having two differing frequencies for location and treatment of e.g tumours
DE59410125D1 (en) 1993-02-10 2002-07-04 Siemens Ag DEVICE FOR PAIN THERAPY AND / OR INFLUENCING THE VEGETATIVE NERVOUS SYSTEM
DE69431741T2 (en) 1993-03-12 2003-09-11 Toshiba Kawasaki Kk Device for medical treatment with ultrasound
US5394877A (en) * 1993-04-01 1995-03-07 Axon Medical, Inc. Ultrasound medical diagnostic device having a coupling medium providing self-adherence to a patient
JP3578217B2 (en) 1993-04-15 2004-10-20 シーメンス アクチエンゲゼルシヤフト Treatment device for treating heart disease and blood vessels near the heart
US5626601A (en) 1995-10-27 1997-05-06 Gary Gershony Vascular sealing apparatus and method
US5716597A (en) 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
US5630837A (en) * 1993-07-01 1997-05-20 Boston Scientific Corporation Acoustic ablation
ATE172370T1 (en) * 1993-07-26 1998-11-15 Technomed Medical Systems ENDOSCOPIC IMAGING AND THERAPY PROBE AND ITS TREATMENT SYSTEM
US5471988A (en) * 1993-12-24 1995-12-05 Olympus Optical Co., Ltd. Ultrasonic diagnosis and therapy system in which focusing point of therapeutic ultrasonic wave is locked at predetermined position within observation ultrasonic scanning range
JPH07184907A (en) * 1993-12-28 1995-07-25 Toshiba Corp Ultrasonic treating device
DE4443947B4 (en) * 1994-01-14 2005-09-22 Siemens Ag endoscope
US5873828A (en) * 1994-02-18 1999-02-23 Olympus Optical Co., Ltd. Ultrasonic diagnosis and treatment system
KR0133481B1 (en) * 1994-03-10 1998-04-23 구자홍 Production method for infrared array sensor using processing
US5507790A (en) * 1994-03-21 1996-04-16 Weiss; William V. Method of non-invasive reduction of human site-specific subcutaneous fat tissue deposits by accelerated lipolysis metabolism
GB9408668D0 (en) 1994-04-30 1994-06-22 Orthosonics Ltd Untrasonic therapeutic system
US5492126A (en) * 1994-05-02 1996-02-20 Focal Surgery Probe for medical imaging and therapy using ultrasound
WO1995029737A1 (en) 1994-05-03 1995-11-09 Board Of Regents, The University Of Texas System Apparatus and method for noninvasive doppler ultrasound-guided real-time control of tissue damage in thermal therapy
FR2720260B1 (en) * 1994-05-30 1996-09-27 Technomed Medical Systems Use of a mode A ultrasound system for monitoring the position of a patient during a therapy session, and method and apparatus comprising same.
US5454373A (en) * 1994-07-20 1995-10-03 Boston Scientific Corporation Medical acoustic imaging
US5534232A (en) 1994-08-11 1996-07-09 Wisconsin Alumini Research Foundation Apparatus for reactions in dense-medium plasmas
US5807285A (en) 1994-08-18 1998-09-15 Ethicon-Endo Surgery, Inc. Medical applications of ultrasonic energy
US5503152A (en) * 1994-09-28 1996-04-02 Tetrad Corporation Ultrasonic transducer assembly and method for three-dimensional imaging
US5609485A (en) * 1994-10-03 1997-03-11 Medsim, Ltd. Medical reproduction system
US5453576A (en) 1994-10-24 1995-09-26 Transonic Systems Inc. Cardiovascular measurements by sound velocity dilution
US5920319A (en) 1994-10-27 1999-07-06 Wake Forest University Automatic analysis in virtual endoscopy
US5520188A (en) 1994-11-02 1996-05-28 Focus Surgery Inc. Annular array transducer
DE4439860C2 (en) * 1994-11-08 1997-04-30 Rwe Dea Ag Device for bringing solids into contact in the form of pourable pieces with liquids and possibly gases
US5711058A (en) * 1994-11-21 1998-01-27 General Electric Company Method for manufacturing transducer assembly with curved transducer array
US5665073A (en) 1995-02-07 1997-09-09 Bulow; Christi Protective sheath and securement apparatus and method for surgical conduits
US5685307A (en) 1995-02-28 1997-11-11 Iowa State University Research Foundation, Inc. Method and apparatus for tissue characterization of animals using ultrasound
US5515853A (en) 1995-03-28 1996-05-14 Sonometrics Corporation Three-dimensional digital ultrasound tracking system
DE69634714T2 (en) 1995-03-31 2006-01-19 Kabushiki Kaisha Toshiba, Kawasaki Therapeutic ultrasound device
US5736796A (en) * 1995-05-01 1998-04-07 Apple Computer, Inc. Printed circuit board having split voltage planes
US5558092A (en) * 1995-06-06 1996-09-24 Imarx Pharmaceutical Corp. Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
US5755228A (en) 1995-06-07 1998-05-26 Hologic, Inc. Equipment and method for calibration and quality assurance of an ultrasonic bone anaylsis apparatus
US5834687A (en) * 1995-06-07 1998-11-10 Acuson Corporation Coupling of acoustic window and lens for medical ultrasound transducers
US5902311A (en) * 1995-06-15 1999-05-11 Perclose, Inc. Low profile intraluminal suturing device and method
US5655538A (en) 1995-06-19 1997-08-12 General Electric Company Ultrasonic phased array transducer with an ultralow impedance backfill and a method for making
US5810007A (en) 1995-07-26 1998-09-22 Associates Of The Joint Center For Radiation Therapy, Inc. Ultrasound localization and image fusion for the treatment of prostate cancer
US5855589A (en) * 1995-08-25 1999-01-05 Mcewen; James A. Physiologic tourniquet for intravenous regional anesthesia
US5931853A (en) 1995-08-25 1999-08-03 Mcewen; James A. Physiologic tourniquet with safety circuit
US5638823A (en) 1995-08-28 1997-06-17 Rutgers University System and method for noninvasive detection of arterial stenosis
US5716374A (en) * 1995-10-10 1998-02-10 Symbiosis Corporation Stamped clevis for endoscopic instruments and method of making the same
US5833647A (en) 1995-10-10 1998-11-10 The Penn State Research Foundation Hydrogels or lipogels with enhanced mass transfer for transdermal drug delivery
US5590657A (en) * 1995-11-06 1997-01-07 The Regents Of The University Of Michigan Phased array ultrasound system and method for cardiac ablation
US5979453A (en) 1995-11-09 1999-11-09 Femrx, Inc. Needle myolysis system for uterine fibriods
US5895356A (en) * 1995-11-15 1999-04-20 American Medical Systems, Inc. Apparatus and method for transurethral focussed ultrasound therapy
US5598845A (en) 1995-11-16 1997-02-04 Stellartech Research Corporation Ultrasound transducer device for continuous imaging of the heart and other body parts
DE19644314A1 (en) * 1995-11-23 1997-05-28 Siemens Ag Therapy appts. with acoustic wave source
JP2000501530A (en) 1995-11-28 2000-02-08 ドルニエ メディカル システムズ,インコーポレイテッド Non-invasive temperature mapping method and system for tissue
US6286989B1 (en) * 1995-12-05 2001-09-11 Ronnald B. King Mixing device with vanes having sloping edges and method of mixing viscous fluids
US5824277A (en) 1995-12-06 1998-10-20 E. I.Du Pont De Nemours And Company Plasma oxidation of an exhaust gas stream from chlorinating titanium-containing material
US5935339A (en) 1995-12-14 1999-08-10 Iowa State University Decontamination device and method thereof
US6261233B1 (en) * 1996-01-05 2001-07-17 Sunlight Medical Ltd. Method and device for a blood velocity determination
US5895357A (en) 1996-01-29 1999-04-20 Aloka Co., Ltd. Bone assessment apparatus
CA2246287C (en) * 1996-02-15 2006-10-24 Biosense, Inc. Medical procedures and apparatus using intrabody probes
US5655539A (en) 1996-02-26 1997-08-12 Abbott Laboratories Method for conducting an ultrasound procedure using an ultrasound transmissive pad
AU1983397A (en) * 1996-02-29 1997-09-16 Acuson Corporation Multiple ultrasound image registration system, method and transducer
US6036687A (en) * 1996-03-05 2000-03-14 Vnus Medical Technologies, Inc. Method and apparatus for treating venous insufficiency
JP3652791B2 (en) 1996-06-24 2005-05-25 独立行政法人科学技術振興機構 Ultrasonic diagnostic equipment
US5681339A (en) 1996-08-12 1997-10-28 Mcewen; James A. Apparatus and method for monitoring the patency of tubing in a pneumatic medical device
DE19635593C1 (en) * 1996-09-02 1998-04-23 Siemens Ag Ultrasound transducer for diagnostic and therapeutic use
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US20050182297A1 (en) 1996-10-04 2005-08-18 Dietrich Gravenstein Imaging scope
US6311692B1 (en) * 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US5769790A (en) * 1996-10-25 1998-06-23 General Electric Company Focused ultrasound surgery system guided by ultrasound imaging
US5827268A (en) * 1996-10-30 1998-10-27 Hearten Medical, Inc. Device for the treatment of patent ductus arteriosus and method of using the device
US5827204A (en) 1996-11-26 1998-10-27 Grandia; Willem Medical noninvasive operations using focused modulated high power ultrasound
USD389574S (en) * 1996-11-27 1998-01-20 Eclipse Surgical Technologies, Inc. Finger grip device for a laser fiber optic delivery system
US6494848B1 (en) * 1996-12-19 2002-12-17 St. Jude Medical Puerto Rico B.V. Measuring device for use with a hemostatic puncture closure device
US5857974A (en) * 1997-01-08 1999-01-12 Endosonics Corporation High resolution intravascular ultrasound transducer assembly having a flexible substrate
US7789841B2 (en) 1997-02-06 2010-09-07 Exogen, Inc. Method and apparatus for connective tissue treatment
US5904659A (en) 1997-02-14 1999-05-18 Exogen, Inc. Ultrasonic treatment for wounds
US5788636A (en) * 1997-02-25 1998-08-04 Acuson Corporation Method and system for forming an ultrasound image of a tissue while simultaneously ablating the tissue
IT1296010B1 (en) 1997-03-18 1999-06-04 Pavis Varese Srl TEXTILE MANUFACTURE FOR THE CLOSURE AND ELASTIC TENSIONING OF A GARMENT OR GARMENT
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US5922945A (en) 1997-04-16 1999-07-13 Abbott Laboratories Method and apparatus for noninvasively analyzing flowable products
US5906580A (en) 1997-05-05 1999-05-25 Creare Inc. Ultrasound system and method of administering ultrasound including a plurality of multi-layer transducer elements
JP2002505596A (en) 1997-05-23 2002-02-19 トランサージカル,インコーポレイテッド MRI guided therapy device and method
US6231507B1 (en) 1997-06-02 2001-05-15 Vnus Medical Technologies, Inc. Pressure tourniquet with ultrasound window and method of use
US5931786A (en) 1997-06-13 1999-08-03 Barzell Whitmore Maroon Bells, Inc. Ultrasound probe support and stepping device
US6042590A (en) * 1997-06-16 2000-03-28 Novomedics, Llc Apparatus and methods for fallopian tube occlusion
JP2002516586A (en) * 1997-06-23 2002-06-04 ティーエイチエス インターナショナル,インコーポレイテッド Method and apparatus for providing acoustic hemostasis
US5957849A (en) * 1997-06-30 1999-09-28 The Regents Of The University Of California Endoluminal ultrasound-guided resectoscope
US5879314A (en) * 1997-06-30 1999-03-09 Cybersonics, Inc. Transducer assembly and method for coupling ultrasonic energy to a body for thrombolysis of vascular thrombi
AU766783B2 (en) 1997-08-19 2003-10-23 Philipp Lang Ultrasonic transmission films and devices, particularly for hygienic transducer surfaces
US6033506A (en) * 1997-09-02 2000-03-07 Lockheed Martin Engery Research Corporation Process for making carbon foam
US6037032A (en) 1997-09-02 2000-03-14 Lockheed Martin Energy Research Corp. Pitch-based carbon foam heat sink with phase change material
US6548047B1 (en) * 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US5964782A (en) * 1997-09-18 1999-10-12 Scimed Life Systems, Inc. Closure device and method
US6078831A (en) 1997-09-29 2000-06-20 Scimed Life Systems, Inc. Intravascular imaging guidewire
US6050943A (en) * 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US6233477B1 (en) 1997-10-20 2001-05-15 Irvine Biomedical, Inc. Catheter system having controllable ultrasound locating means
US6071239A (en) 1997-10-27 2000-06-06 Cribbs; Robert W. Method and apparatus for lipolytic therapy using ultrasound energy
US9198635B2 (en) * 1997-10-31 2015-12-01 University Of Washington Method and apparatus for preparing organs and tissues for laparoscopic surgery
US5951476A (en) 1997-11-14 1999-09-14 Beach; Kirk Watson Method for detecting brain microhemorrhage
US6120453A (en) 1997-11-17 2000-09-19 Sharp; William A. Three-dimensional ultrasound system based on the coordination of multiple ultrasonic transducers
US6280388B1 (en) 1997-11-19 2001-08-28 Boston Scientific Technology, Inc. Aerogel backed ultrasound transducer
US5919139A (en) 1997-12-19 1999-07-06 Diasonics Ultrasound Vibrational doppler ultrasonic imaging
US6406759B1 (en) 1998-01-08 2002-06-18 The University Of Tennessee Research Corporation Remote exposure of workpieces using a recirculated plasma
WO1999035893A2 (en) * 1998-01-08 1999-07-15 The University Of Tennessee Research Corporation Paraelectric gas flow accelerator
CN1058905C (en) * 1998-01-25 2000-11-29 重庆海扶(Hifu)技术有限公司 High-intensity focus supersonic tumor scanning therapy system
US6562037B2 (en) * 1998-02-12 2003-05-13 Boris E. Paton Bonding of soft biological tissues by passing high frequency electric current therethrough
US5997481A (en) 1998-02-17 1999-12-07 Ultra Sound Probe Covers, Llc Probe cover with deformable membrane gel reservoir
US6013031A (en) * 1998-03-09 2000-01-11 Mendlein; John D. Methods and devices for improving ultrasonic measurements using anatomic landmarks and soft tissue correction
US6246156B1 (en) 1998-03-27 2001-06-12 Ngk Insulators, Ltd. Piezoelectric/electrostrictive element
US5935144A (en) 1998-04-09 1999-08-10 Ethicon Endo-Surgery, Inc. Double sealed acoustic isolation members for ultrasonic
US6106463A (en) 1998-04-20 2000-08-22 Wilk; Peter J. Medical imaging device and associated method including flexible display
MXPA00010847A (en) 1998-05-06 2002-05-08 Exogen Inc Ultrasound bandages.
FR2778573B1 (en) * 1998-05-13 2000-09-22 Technomed Medical Systems FREQUENCY ADJUSTMENT IN A HIGH INTENSITY FOCUSED ULTRASOUND TREATMENT APPARATUS
US5976092A (en) 1998-06-15 1999-11-02 Chinn; Douglas O. Combination stereotactic surgical guide and ultrasonic probe
US6039694A (en) * 1998-06-25 2000-03-21 Sonotech, Inc. Coupling sheath for ultrasound transducers
US6042556A (en) * 1998-09-04 2000-03-28 University Of Washington Method for determining phase advancement of transducer elements in high intensity focused ultrasound
US6036650A (en) * 1998-09-15 2000-03-14 Endosonics Corporation Ultrasonic imaging system and method with ringdown reduction
US6425867B1 (en) * 1998-09-18 2002-07-30 University Of Washington Noise-free real time ultrasonic imaging of a treatment site undergoing high intensity focused ultrasound therapy
US6277077B1 (en) 1998-11-16 2001-08-21 Cardiac Pathways Corporation Catheter including ultrasound transducer with emissions attenuation
US6254601B1 (en) * 1998-12-08 2001-07-03 Hysterx, Inc. Methods for occlusion of the uterine arteries
US6213939B1 (en) * 1998-12-10 2001-04-10 Mcewen James Allen Hazard monitor for surgical tourniquet systems
US6102860A (en) 1998-12-24 2000-08-15 Agilent Technologies, Inc. Ultrasound transducer for three-dimensional imaging
US6206843B1 (en) * 1999-01-28 2001-03-27 Ultra Cure Ltd. Ultrasound system and methods utilizing same
US6248124B1 (en) * 1999-02-22 2001-06-19 Tyco Healthcare Group Arterial hole closure apparatus
US6270458B1 (en) 1999-03-05 2001-08-07 Barnev Inc. Cervix dilation and labor progression monitor
US6193660B1 (en) * 1999-03-31 2001-02-27 Acuson Corporation Medical diagnostic ultrasound system and method for region of interest determination
IL129461A0 (en) 1999-04-15 2000-02-29 F R A Y Project Dev Ltd 3-D ultrasound imaging system
US6179831B1 (en) * 1999-04-29 2001-01-30 Galil Medical Ltd. Method of cryoablating benign prostate hyperplasia
US6259945B1 (en) 1999-04-30 2001-07-10 Uromed Corporation Method and device for locating a nerve
US6217530B1 (en) * 1999-05-14 2001-04-17 University Of Washington Ultrasonic applicator for medical applications
FR2794018B1 (en) * 1999-05-26 2002-05-24 Technomed Medical Systems ULTRASONIC LOCATION AND TREATMENT APPARATUS
US7534209B2 (en) 2000-05-26 2009-05-19 Physiosonics, Inc. Device and method for mapping and tracking blood flow and determining parameters of blood flow
US6682483B1 (en) * 1999-05-28 2004-01-27 Vuesonix Sensors, Inc. Device and method for mapping and tracking blood flow and determining parameters of blood flow
US6398792B1 (en) * 1999-06-21 2002-06-04 O'connor Lawrence Angioplasty catheter with transducer using balloon for focusing of ultrasonic energy and method for use
US6533726B1 (en) 1999-08-09 2003-03-18 Riverside Research Institute System and method for ultrasonic harmonic imaging for therapy guidance and monitoring
US6361548B1 (en) * 1999-08-20 2002-03-26 Mcewen James Allen Limb protection sleeve for matching tourniquet cuff
US6706892B1 (en) * 1999-09-07 2004-03-16 Conjuchem, Inc. Pulmonary delivery for bioconjugation
US6599256B1 (en) 1999-09-10 2003-07-29 Transurgical, Inc. Occlusion of tubular anatomical structures by energy application
US6200268B1 (en) * 1999-09-10 2001-03-13 The Cleveland Clinic Foundation Vascular plaque characterization
US7510536B2 (en) * 1999-09-17 2009-03-31 University Of Washington Ultrasound guided high intensity focused ultrasound treatment of nerves
US6231561B1 (en) * 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US6443894B1 (en) 1999-09-29 2002-09-03 Acuson Corporation Medical diagnostic ultrasound system and method for mapping surface data for three dimensional imaging
US6868739B1 (en) * 1999-10-19 2005-03-22 Transonic Systems, Inc. Method and apparatus to measure blood flow by an introduced volume change
US20050240170A1 (en) * 1999-10-25 2005-10-27 Therus Corporation Insertable ultrasound probes, systems, and methods for thermal therapy
AU2619301A (en) * 1999-10-25 2001-06-06 Therus Corporation Use of focused ultrasound for vascular sealing
US6626855B1 (en) * 1999-11-26 2003-09-30 Therus Corpoation Controlled high efficiency lesion formation using high intensity ultrasound
WO2001045550A2 (en) 1999-12-23 2001-06-28 Therus Corporation Ultrasound transducers for imaging and therapy
US7706882B2 (en) * 2000-01-19 2010-04-27 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area
US6409720B1 (en) 2000-01-19 2002-06-25 Medtronic Xomed, Inc. Methods of tongue reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6595934B1 (en) * 2000-01-19 2003-07-22 Medtronic Xomed, Inc. Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6520915B1 (en) * 2000-01-28 2003-02-18 U-Systems, Inc. Ultrasound imaging system with intrinsic doppler capability
EP1257209A1 (en) 2000-02-10 2002-11-20 Harmonia Medical Technologies Inc. Transurethral volume reduction of the prostate (tuvor)
US20020032394A1 (en) * 2000-03-08 2002-03-14 Axel Brisken Methods, systems, and kits for plaque stabilization
US6633658B1 (en) 2000-03-17 2003-10-14 Senorx, Inc. System and method for managing intermittent interference on imaging systems
US6905498B2 (en) 2000-04-27 2005-06-14 Atricure Inc. Transmural ablation device with EKG sensor and pacing electrode
WO2001082811A1 (en) 2000-04-27 2001-11-08 Medtronic, Inc. System and method for assessing transmurality of ablation lesions
WO2001087169A1 (en) 2000-05-16 2001-11-22 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
US6612988B2 (en) 2000-08-29 2003-09-02 Brigham And Women's Hospital, Inc. Ultrasound therapy
US6522926B1 (en) * 2000-09-27 2003-02-18 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US6845267B2 (en) 2000-09-28 2005-01-18 Advanced Bionics Corporation Systems and methods for modulation of circulatory perfusion by electrical and/or drug stimulation
US6955648B2 (en) * 2000-09-29 2005-10-18 New Health Sciences, Inc. Precision brain blood flow assessment remotely in real time using nanotechnology ultrasound
IL138926A0 (en) 2000-10-06 2001-11-25 Notal Vision Ltd Method and system for detecting eye disease
US6524246B1 (en) 2000-10-13 2003-02-25 Sonocine, Inc. Ultrasonic cellular tissue screening tool
US6616624B1 (en) 2000-10-30 2003-09-09 Cvrx, Inc. Systems and method for controlling renovascular perfusion
US6679855B2 (en) 2000-11-07 2004-01-20 Gerald Horn Method and apparatus for the correction of presbyopia using high intensity focused ultrasound
US7022077B2 (en) 2000-11-28 2006-04-04 Allez Physionix Ltd. Systems and methods for making noninvasive assessments of cardiac tissue and parameters
JP2004520870A (en) 2000-11-28 2004-07-15 アレズ フィジオニックス リミテッド Non-invasive physiological evaluation system and method
US20030009194A1 (en) * 2000-12-07 2003-01-09 Saker Mark B. Tissue tract sealing device
SE0100160D0 (en) 2001-01-22 2001-01-22 Atos Medical Ab Method and apparatus for high energetic ultrasonic tissue treatment
US7053092B2 (en) * 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
US6785571B2 (en) 2001-03-30 2004-08-31 Neil David Glossop Device and method for registering a position sensor in an anatomical body
WO2002087692A1 (en) 2001-04-26 2002-11-07 The Procter & Gamble Company A method and apparatus for the treatment of cosmetic skin conditioins
US6576168B2 (en) 2001-05-22 2003-06-10 Poco Graphite, Inc. Process for making carbon foam induced by process depressurization
US6559644B2 (en) 2001-05-30 2003-05-06 Insightec - Txsonics Ltd. MRI-based temperature mapping with error compensation
WO2002100486A1 (en) 2001-06-07 2002-12-19 Takashi Okai Method and apparatus for treating uterine myoma
US6735461B2 (en) 2001-06-19 2004-05-11 Insightec-Txsonics Ltd Focused ultrasound system with MRI synchronization
US6932771B2 (en) 2001-07-09 2005-08-23 Civco Medical Instruments Co., Inc. Tissue warming device and method
FR2827149B1 (en) 2001-07-13 2003-10-10 Technomed Medical Systems FOCUSED ULTRASOUND TREATMENT PROBE
US20040078034A1 (en) * 2001-07-16 2004-04-22 Acker David E Coagulator and spinal disk surgery
US6682547B2 (en) * 2001-08-14 2004-01-27 Mcewen James Allen Tourniquet cuff with identification apparatus
US20030069569A1 (en) * 2001-08-29 2003-04-10 Burdette Everette C. Ultrasound device for treatment of intervertebral disc tissue
US6702835B2 (en) * 2001-09-07 2004-03-09 Core Medical, Inc. Needle apparatus for closing septal defects and methods for using such apparatus
US6709407B2 (en) * 2001-10-30 2004-03-23 Mayo Foundation For Medical Education And Research Method and apparatus for fetal audio stimulation
KR101014734B1 (en) 2001-11-29 2011-02-15 시바우라 메카트로닉스 가부시끼가이샤 Apparatus for producing photocatalyst element
US20050101841A9 (en) * 2001-12-04 2005-05-12 Kimberly-Clark Worldwide, Inc. Healthcare networks with biosensors
US6780155B2 (en) 2001-12-18 2004-08-24 Koninklijke Philips Electronics Method and system for ultrasound blood flow imaging and volume flow calculations
SE520858C2 (en) * 2002-01-15 2003-09-02 Ultrazonix Dnt Ab Device with both therapeutic and diagnostic sensors for non-invasive ultrasound treatment of an object
US6755789B2 (en) 2002-02-05 2004-06-29 Inceptio Medical Technologies, Llc Ultrasonic vascular imaging system and method of blood vessel cannulation
US6719699B2 (en) 2002-02-07 2004-04-13 Sonotech, Inc. Adhesive hydrophilic membranes as couplants in ultrasound imaging applications
DE10209380B4 (en) 2002-03-02 2009-01-15 Richard Wolf Gmbh Shock wave converter
US7128711B2 (en) 2002-03-25 2006-10-31 Insightec, Ltd. Positioning systems and methods for guided ultrasound therapy systems
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US7162303B2 (en) * 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US20030208101A1 (en) 2002-05-03 2003-11-06 Cecchi Michael D. Embryo-implanting catheter control system and method of the same
AU2003261073A1 (en) * 2002-05-16 2003-12-02 Barbara Ann Karmanos Cancer Institute Combined diagnostic and therapeutic ultrasound system
WO2004006774A2 (en) 2002-07-12 2004-01-22 Iscience Surgical Corporation Ultrasound interfacing device for tissue imaging
US7211045B2 (en) 2002-07-22 2007-05-01 Ep Medsystems, Inc. Method and system for using ultrasound in cardiac diagnosis and therapy
US6964782B1 (en) * 2002-07-23 2005-11-15 Tec Labs, Inc. Stable hydrogen peroxide compositions, products and methods of use
US20040054287A1 (en) * 2002-08-29 2004-03-18 Stephens Douglas Neil Ultrasonic imaging devices and methods of fabrication
US20040122493A1 (en) 2002-09-09 2004-06-24 Kabushiki Kaisha Toshiba Ultrasonic irradiation apparatus
US20040059265A1 (en) * 2002-09-12 2004-03-25 The Regents Of The University Of California Dynamic acoustic focusing utilizing time reversal
US7052463B2 (en) 2002-09-25 2006-05-30 Koninklijke Philips Electronics, N.V. Method and apparatus for cooling a contacting surface of an ultrasound probe
US7260250B2 (en) 2002-09-30 2007-08-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Computer-aided classification of anomalies in anatomical structures
US6709392B1 (en) * 2002-10-10 2004-03-23 Koninklijke Philips Electronics N.V. Imaging ultrasound transducer temperature control system and method using feedback
US7697972B2 (en) 2002-11-19 2010-04-13 Medtronic Navigation, Inc. Navigation system for cardiac therapies
US6846291B2 (en) * 2002-11-20 2005-01-25 Sonotech, Inc. Production of lubricious coating on adhesive hydrogels
US6831394B2 (en) * 2002-12-11 2004-12-14 General Electric Company Backing material for micromachined ultrasonic transducer devices
US20040158154A1 (en) * 2003-02-06 2004-08-12 Siemens Medical Solutions Usa, Inc. Portable three dimensional diagnostic ultrasound imaging methods and systems
US7684865B2 (en) * 2003-03-14 2010-03-23 Endovx, Inc. Methods and apparatus for treatment of obesity
EP1479412B1 (en) 2003-05-19 2008-10-22 UST Inc. Geometrically shaped coupling hydrogel standoffs for high intensity focused ultrasound
US7074218B2 (en) 2003-06-30 2006-07-11 Ethicon, Inc. Multi-modality ablation device
US8354773B2 (en) * 2003-08-22 2013-01-15 Siemens Medical Solutions Usa, Inc. Composite acoustic absorber for ultrasound transducer backing material
US20050165298A1 (en) 2003-09-04 2005-07-28 Crum, Kaminski & Larson, Llc Treatment of cardiac tissue following myocardial infarction utilizing high intensity focused ultrasound
US20050065436A1 (en) * 2003-09-23 2005-03-24 Ho Winston Zonh Rapid and non-invasive optical detection of internal bleeding
AU2004214572B2 (en) * 2003-09-30 2010-04-29 Olympus Corporation Inserting shape detecting probe
US7285093B2 (en) 2003-10-10 2007-10-23 Imadent Ltd. systems for ultrasonic imaging of a jaw, methods of use thereof and coupling cushions suited for use in the mouth
US20050090104A1 (en) 2003-10-27 2005-04-28 Kai Yang Slurry compositions for chemical mechanical polishing of copper and barrier films
US20050124884A1 (en) 2003-12-05 2005-06-09 Mirsaid Bolorforosh Multidimensional transducer systems and methods for intra patient probes
US7125383B2 (en) 2003-12-30 2006-10-24 General Electric Company Method and apparatus for ultrasonic continuous, non-invasive blood pressure monitoring
US6957849B2 (en) * 2004-01-02 2005-10-25 Ford Global Technologies, Llc Windshield stop for cowl vent grille attachment
EP1718194A4 (en) 2004-01-20 2010-05-12 Topspin Medical Israel Ltd Mri probe for prostate imaging
ATE523141T1 (en) 2004-02-17 2011-09-15 Philips Electronics Ltd METHOD AND DEVICE FOR REGISTRATION, VERIFICATION OF AND REFERENCE TO BODY ORGANS
US7654958B2 (en) 2004-04-20 2010-02-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for ultrasound imaging with autofrequency selection
US8727987B2 (en) 2004-05-06 2014-05-20 Nanyang Technological University Mechanical manipulator for HIFU transducers
GB2445322B (en) 2004-08-13 2008-08-06 Stichting Tech Wetenschapp Intravasular ultrasound techniques
US8409099B2 (en) * 2004-08-26 2013-04-02 Insightec Ltd. Focused ultrasound system for surrounding a body tissue mass and treatment method
US7530958B2 (en) 2004-09-24 2009-05-12 Guided Therapy Systems, Inc. Method and system for combined ultrasound treatment
WO2006051542A1 (en) * 2004-11-12 2006-05-18 Kpe Ltd. Nanoparticle mediated ultrasound therapy and diagnostic imaging
CA2587522A1 (en) 2004-11-15 2006-05-26 Christopher Decharms Stimulation of neural tissue with light
US7713210B2 (en) 2004-11-23 2010-05-11 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for localizing an ultrasound catheter
US7553284B2 (en) 2005-02-02 2009-06-30 Vaitekunas Jeffrey J Focused ultrasound for pain reduction
US7499748B2 (en) * 2005-04-11 2009-03-03 Cardiac Pacemakers, Inc. Transvascular neural stimulation device
KR20130046446A (en) 2005-04-14 2013-05-07 베라소닉스, 인코포레이티드 Ultrasound imaging system with pixel oriented processing
US7621873B2 (en) * 2005-08-17 2009-11-24 University Of Washington Method and system to synchronize acoustic therapy with ultrasound imaging
WO2007025244A2 (en) 2005-08-25 2007-03-01 Houle Philip R Treatment systems for delivery of sensitizer solutions
US20070213616A1 (en) 2005-10-20 2007-09-13 Thomas Anderson Systems and methods for arteriotomy localization
CN101674862A (en) 2005-11-10 2010-03-17 电子核心公司 Electrical stimulation treatment of bronchial constriction
US20070167806A1 (en) 2005-11-28 2007-07-19 Koninklijke Philips Electronics N.V. Multi-modality imaging and treatment
EP1962949B1 (en) 2005-12-20 2015-02-25 The Cleveland Clinic Foundation Apparatus for modulating the baroreflex system
US20070149880A1 (en) 2005-12-22 2007-06-28 Boston Scientific Scimed, Inc. Device and method for determining the location of a vascular opening prior to application of HIFU energy to seal the opening
US20080039746A1 (en) * 2006-05-25 2008-02-14 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
CN101610735B (en) * 2006-06-28 2015-07-01 美敦力Af卢森堡公司 Methods and systems for thermally-induced renal neuromodulation
US7469572B2 (en) * 2006-07-17 2008-12-30 Kci Licensing, Inc. Measurement of moisture vapor transfer rate
US20080033292A1 (en) * 2006-08-02 2008-02-07 Insightec Ltd Ultrasound patient interface device
CN100574829C (en) 2006-08-24 2009-12-30 重庆融海超声医学工程研究中心有限公司 A kind of high-strength focus supersonic therapeutic system of image documentation equipment guiding
US20080317204A1 (en) 2007-03-16 2008-12-25 Cyberheart, Inc. Radiation treatment planning and delivery for moving targets in the heart
US20080299177A1 (en) 2007-06-06 2008-12-04 Biovaluation & Analysis, Inc. Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
WO2009026534A1 (en) 2007-08-23 2009-02-26 Verasonics, Inc. Adaptive ultrasound image reconstruction based on sensing of local media motion
US8251908B2 (en) 2007-10-01 2012-08-28 Insightec Ltd. Motion compensated image-guided focused ultrasound therapy system
US10035027B2 (en) 2007-10-31 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Device and method for ultrasonic neuromodulation via stereotactic frame based technique
WO2009070245A2 (en) 2007-11-21 2009-06-04 Focus Surgery, Inc. Method of diagnosis and treatment of tumors using high intensity focused ultrasound
US20090247911A1 (en) 2008-03-25 2009-10-01 Petr Novak Multiple-angle switched high intensity focused ultrasound
US20090264755A1 (en) 2008-04-22 2009-10-22 National Taiwan University High-Intensity Ultrasonic Vessel Ablator Using Blood Flow Signal for Precise Positioning
EP2662046B1 (en) 2008-05-09 2023-03-15 Nuvaira, Inc. Systems and assemblies for treating a bronchial tree
DK2303131T3 (en) 2008-06-26 2015-05-04 Verasonics Inc Quantitative Doppler flow imaging with high frame rate using unfocused transmission rays
EP2813192A3 (en) 2008-10-21 2015-04-15 Microcube, LLC Methods and devices for applying energy to bodily tissues
KR101143645B1 (en) * 2009-07-29 2012-05-09 주세은 Transcranial low-intensity ultrasound delivery device and non-invasive modulation of brain function

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5810810A (en) * 1992-04-23 1998-09-22 Scimed Life Systems, Inc. Apparatus and method for sealing vascular punctures
US5383896A (en) * 1993-05-25 1995-01-24 Gershony; Gary Vascular sealing device
US6007499A (en) * 1997-10-31 1999-12-28 University Of Washington Method and apparatus for medical procedures using high-intensity focused ultrasound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1229839A2 *

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
US8968284B2 (en) 2000-10-02 2015-03-03 Verathon Inc. Apparatus and methods for treating female urinary incontinence
US8465482B2 (en) 2000-10-02 2013-06-18 Verathon, Inc. Apparatus and methods for treating female urinary incontinence
US8177781B2 (en) 2000-10-02 2012-05-15 Novasys Medical, Inc. Apparatus and methods for treating female urinary incontinence
EP1427343A4 (en) * 2001-05-29 2006-07-12 Ethicon Endo Surgery Inc Ultrasound-based occlusive procedure for medical treatment
EP1427343A2 (en) * 2001-05-29 2004-06-16 Ethicon Endo-Surgery, Inc. Ultrasound-based occlusive procedure for medical treatment
JP2009297527A (en) * 2002-07-25 2009-12-24 Novasys Medical Inc Apparatus and method for treating female urinary incontinence
US7713203B2 (en) 2004-07-23 2010-05-11 Inserm And Theraclion Ultrasound treatment device and method
WO2006021651A1 (en) 2004-07-23 2006-03-02 Inserm Ultrasound treating device and method
US8137276B2 (en) 2005-12-14 2012-03-20 Koninklijke Philips Electronics N.V. Method and apparatus for guidance and application of high intensity focused ultrasound for control of bleeding due to severed limbs
WO2007069154A1 (en) 2005-12-14 2007-06-21 Koninklijke Philips Electronics N.V. Method and apparatus for guidance and application of high intensity focused ultrasound for control of bleeding due to severed limbs
WO2007069156A1 (en) * 2005-12-14 2007-06-21 Koninklijke Philips Electronics, N.V. Transducer cuff for guidance and application of high intensity focused ultrasound for control of bleeding due to severed limbs
WO2008024553A1 (en) * 2006-08-24 2008-02-28 Boston Scientific Scimed, Inc. Blood vessel puncture locating apparatus and method
US9630030B2 (en) 2007-06-25 2017-04-25 International Cardio Corporation Image guided plaque ablation
US9144693B2 (en) 2007-06-25 2015-09-29 International Cardio Corporation Image guided plaque ablation
EP2482733A1 (en) * 2009-09-29 2012-08-08 Liposonix, Inc. Variable treatment site body contouring using an ultrasound therapy device
EP2482733A4 (en) * 2009-09-29 2014-05-14 Liposonix Inc Variable treatment site body contouring using an ultrasound therapy device
US9125642B2 (en) 2009-10-12 2015-09-08 Kona Medical, Inc. External autonomic modulation
US9358401B2 (en) 2009-10-12 2016-06-07 Kona Medical, Inc. Intravascular catheter to deliver unfocused energy to nerves surrounding a blood vessel
US8556834B2 (en) 2009-10-12 2013-10-15 Kona Medical, Inc. Flow directed heating of nervous structures
US8512262B2 (en) 2009-10-12 2013-08-20 Kona Medical, Inc. Energetic modulation of nerves
US8986211B2 (en) 2009-10-12 2015-03-24 Kona Medical, Inc. Energetic modulation of nerves
US8986231B2 (en) 2009-10-12 2015-03-24 Kona Medical, Inc. Energetic modulation of nerves
US8992447B2 (en) 2009-10-12 2015-03-31 Kona Medical, Inc. Energetic modulation of nerves
US9005143B2 (en) 2009-10-12 2015-04-14 Kona Medical, Inc. External autonomic modulation
US8469904B2 (en) 2009-10-12 2013-06-25 Kona Medical, Inc. Energetic modulation of nerves
US9119952B2 (en) 2009-10-12 2015-09-01 Kona Medical, Inc. Methods and devices to modulate the autonomic nervous system via the carotid body or carotid sinus
US9119951B2 (en) 2009-10-12 2015-09-01 Kona Medical, Inc. Energetic modulation of nerves
US11154356B2 (en) 2009-10-12 2021-10-26 Otsuka Medical Devices Co., Ltd. Intravascular energy delivery
US9199097B2 (en) 2009-10-12 2015-12-01 Kona Medical, Inc. Energetic modulation of nerves
US9174065B2 (en) 2009-10-12 2015-11-03 Kona Medical, Inc. Energetic modulation of nerves
US8374674B2 (en) 2009-10-12 2013-02-12 Kona Medical, Inc. Nerve treatment system
US9352171B2 (en) 2009-10-12 2016-05-31 Kona Medical, Inc. Nerve treatment system
US8715209B2 (en) 2009-10-12 2014-05-06 Kona Medical, Inc. Methods and devices to modulate the autonomic nervous system with ultrasound
US9579518B2 (en) 2009-10-12 2017-02-28 Kona Medical, Inc. Nerve treatment system
US8295912B2 (en) 2009-10-12 2012-10-23 Kona Medical, Inc. Method and system to inhibit a function of a nerve traveling with an artery
US8517962B2 (en) 2009-10-12 2013-08-27 Kona Medical, Inc. Energetic modulation of nerves
US10772681B2 (en) 2009-10-12 2020-09-15 Utsuka Medical Devices Co., Ltd. Energy delivery to intraparenchymal regions of the kidney
US10925579B2 (en) 2014-11-05 2021-02-23 Otsuka Medical Devices Co., Ltd. Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery
CN110547852A (en) * 2018-05-31 2019-12-10 柯惠有限合伙公司 method and system for ultrasonic vascular sealing
US11540856B2 (en) 2018-05-31 2023-01-03 Covidien Lp Methods and systems for ultrasonic vessel sealing

Also Published As

Publication number Publication date
EP1229839A4 (en) 2005-12-07
US20110118602A1 (en) 2011-05-19
US20070179379A1 (en) 2007-08-02
US20110021913A1 (en) 2011-01-27
US20120059258A1 (en) 2012-03-08
JP2003513691A (en) 2003-04-15
US8388535B2 (en) 2013-03-05
US20120108966A1 (en) 2012-05-03
US20120108967A1 (en) 2012-05-03
US20110178445A1 (en) 2011-07-21
US20110178403A1 (en) 2011-07-21
AU2619301A (en) 2001-06-06
US20040106880A1 (en) 2004-06-03
US6656136B1 (en) 2003-12-02
WO2001034018A3 (en) 2002-01-10
US8277398B2 (en) 2012-10-02
EP1229839A2 (en) 2002-08-14
US8137274B2 (en) 2012-03-20
CA2387127A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
US6656136B1 (en) Use of focused ultrasound for vascular sealing
US7553284B2 (en) Focused ultrasound for pain reduction
US8372009B2 (en) System and method for treating a therapeutic site
EP1962694B1 (en) Device for determining the location of a vascular opening prior to application of hifu energy to seal the opening
CA2253664C (en) Methods and devices for providing acoustic hemostasis
US5993389A (en) Devices for providing acoustic hemostasis
US9198635B2 (en) Method and apparatus for preparing organs and tissues for laparoscopic surgery
WO1996000037A9 (en) Surgical instrument with ultrasound pulse generator
EP0767627A1 (en) Surgical instrument with ultrasound pulse generator
JPH10328194A (en) Ultrasonic therapy instrument
JPH0747079A (en) Ultrasonic therapeutic system
US20200139159A1 (en) Control method for the treatment of brain tissue

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2387127

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000989717

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 536034

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000989717

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642